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Although rates of morbidity and mortality from cardiovascular disease have 
improved over the past decades, racial disparities in cardiovascular disease risk have 
persisted for ethnic and racial minorities. Research seeking to explain these disparities 
has largely focused on traditional risk factors such as obesity, hypertension, diet, and 
physical activity.  However, a large body of literature has evidenced the psychological 
and social implications of race on cardiovascular risk.   
The weathering hypothesis posits that stress associated with racial inequities, 
racism, and discrimination may cause physiological deterioration among African 
Americans as early as young adulthood, thus contributing to cardiovascular disease 
disparities.  Allostatic load is widely accepted as a quantitative metric used to study the 
consequences of weathering. This metric provides researchers with the ability to measure 
both the acute and long-term outcomes of the stress response. Measurement of allostatic 
load is based on a set of biomarkers that represent the current status of each physiological 
system that responds to stress (e.g. hypothalamic-pituitary-adrenal (HPA) axis, 
cardiovascular system, metabolic processes and the immune system).  An algorithm is 
then used to compute allostatic load by demarcating clinical cut points to dichotomize 
continuous biological measurement into binary high risk variables (0 = low, 1 = high). 
This value is then summed to yield an allostatic load score which determines the presence 
of allostatic load. There are three important limitations to this approach.  First, clinical 
 
 
 
 
cut points may not capture the full extent of biological risk.  Second, categorizing 
otherwise continuous data results in loss of valuable information captured by the 
variables used to calculate allostatic load. Third, it is improbable that each biomarker 
equally contributes to the calculation of an allostatic score.   
The purpose of this study was to expand the weathering hypothesis by developing 
cardiovascular risk profiles using latent profile analyses on biomarkers commonly used in 
allostatic load calculations as an alternative to the traditional algorithm.. In addition, this 
study examined the relationship between demographic variables (race, age, sex, SES), 
psychosocial factors (depression, social support) and membership in cardiovascular 
disease risk profiles. Initial analysis using a national sample of a population age 3 to 85 
identified four profile groups; low overall risk, kidney risk, vascular risk, and 
inflammation risk. Compared to Whites, Hispanics were more likely to exhibit an 
inflammation risk profile while African Americans were more likely to exhibit both 
inflammatory and vascular risk profiles.  In addition, age, sex, and poverty to income 
ratio were significant predictors of all risk profiles. When focusing on depression and 
social support in a sample of individuals 40 years and older, analysis identified two 
profile groups; a low overall risk profile and an inflammation risk profile. Compared to 
Whites, African Americans were more likely to be members of the inflammatory risk 
profile.  Further, an increase in depression score significantly increased the odds of an 
inflammatory risk profile membership. Moreover, the relationship between inflammation 
risk profile membership and social support (emotional, financial, social network) was 
examined in which no significant relationship was found. However, analysis revealed that 
 
 
 
 
the relationship between depression and inflammatory risk was moderated by emotional 
support, such that having received emotional support significantly decreased the 
association between depression and inflammatory risk.  
Findings from this study suggests that examining cardiovascular risk profiles that 
account for age, race, sex, and socioeconomic status may be useful for extending the 
weathering hypothesis and identifying different patterns of risk among those who 
experience allostatic load. Further understanding of the racial differences in depression 
and inflammatory risk may be beneficial in eliminating disparities in cardiovascular 
disease. Results from this project indicate that a higher level of emotional support may be 
promising strategy to reduce cardiovascular risk.  
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CHAPTER I 
 
INTRODUCTION 
 
 
Statement of Problem 
 
Of all racial and ethnic groups, African American have the highest mortality rates 
in coronary artery disease, hypertension, stroke, and congestive heart failure (Go et al., 
2014). Though overall rates of cardiovascular disease (CVD) have decreased in the 
United States, CVD disparities among African Americans have remained. Understanding 
differential cardiovascular risk factors between African Americans and their counterparts 
may provide insights into persistent CVD disparities. Current research suggests 
broadening risk identification from traditional risk factors (i.e. lifestyle, and genetics) to 
risk factors associated with stress.  
The weathering hypothesis which has to date focused solely on race related stress 
may also be employed to explain how disproportional rates of depression among 
minorities account for some CVD disparities. This hypothesis proposes that chronic stress 
over the lifespan accelerates biological weathering among minorities (Geronimus, 2000; 
Geronimus & Thompson, 2004). The weathering hypothesis posits that stress associated 
with racial inequities may cause health deterioration among African Americans as early 
as young adulthood, leading to racial disparities in health outcomes over the life span.  
African Americans often report stress associated with perceived racism and 
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discrimination which has been shown to contribute to depressive symptomology (Banks 
& Kohn-Wood, 2007; Flores et al., 2008).  
African Americans can experience racism and discrimination on multiple levels, 
including interpersonal (discriminatory interactions between individuals), institutional 
(discrimination in employment, housing, or health care), and cultural (widespread 
acceptance of stereotypes) (Harrell, 2000; Jones, 2000; Krieger, 1999).    Racism also 
increases the likelihood of objective stress from stressors such as job insecurity and 
financial strain that can promote depressive symptomology (Arrow, 1998; Pager & 
Shepherd, 2008; Mezuk, Rafferty, et al., 2010).  Sellers and colleagues (2006) found the 
racial discrimination reduced psychological well-being, while increasing depressive 
symptoms and perceived stress (Sellers, Copeland-Linder, Martin, & Lewis, 2006).  
Further, racism has been shown to facilitate depressive symptoms by threatening self-
esteem, invoking  sense of hopelessness, and normalizing failure (Clark, Anderson, 
Clark, & Williams, 1999).  
Evidence suggests there is a complex and bidirectional relationship between 
cardiovascular disease and depression  (Lippi, Montagnana, Favaloro, & Franchini, 
2009).  Cardiovascular disease has been shown to contribute to the onset of depressive 
symptoms.   One out of every five patients with cardiovascular disease will report a major 
depressive disorder (Thombs et al., 2006).  Moreover, a growing body of literature 
provides evidence that depression increases the risk of cardiovascular disease. 
Researchers have found that an increase a depressive symptomology predicts incidence 
of coronary artery disease, coronary heart disease, myocardial infarction (Barefoot & 
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Schroll, 1996; Charlson, Stapelberg, Baxter, & Whiteford, 2011; Ferketich, 
Schwartzbaum, Frid, & Moeschberger, 2000; Keyes, 2004; Van der Kooy et al., 2007).  
Further, depression has also been shown to worsen cardiovascular disease prognosis and 
increase overall mortality from cardiovascular disease  (Barth, Schumacher, & 
Herrmann-Lingen, 2004; Ferketich et al., 2000; Frasure-Smith et al., 2000, 2000; Lett et 
al., 2004; Van Melle et al., 2004). Thus, the nature of the relationship between depression 
and cardiovascular disease is unclear and the mechanism for the complex interplay 
between depression and cardiovascular diseases remains unexplained.  
Depression, particularly chronic depression, represents a persistent stress state 
which may erode the physiological systems that adapt to stress ( McEwen, 1998; 
McEwen, 2003; Juster et al., 2011; Kobrosly, van Wijngaarden, Seplaki, Cory-Slechta, & 
Moynihan, 2014). Allostasis, the process of stress adaptation, activates the sympathetic 
nervous, hypothalamic-pituitary-adrenal axis (HPA) and the immune systems. Allostatic 
load is the consequence of chronic allostasis activation. In an allostatic load state, the 
physiological stress response becomes impaired, reducing the ability to functionally adapt 
to future stressors (Seplaki, Goldman, Weinstein, & Lin, 2004).  
Research has documented a relationship between allostatic load and CVD  
(Geronimus, 1996; B. McEwen, 1998; Merkin, Karlamangla, Diez Roux, Shrager, & 
Seeman, 2014; Merkin et al., 2014; Seeman, Singer, Rowe, Horwitz, & McEwen, 1997; 
M. G. Taylor, 2008). Moreover, depression has been shown to alter a number of 
biological mechanisms, including autonomic nervous system function, HPA axis 
function, inflammations and insulin resistance (Joynt, Whellan, & O’Connor, 2003; 
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Kiecolt-Glaser & Glaser, 2002; Lett et al., 2004; B. S. McEwen, 2003; Miller, Stetler, 
Carney, Freedland, & Banks, 2002; C. B. Taylor, 2010; Thayer, Yamamoto, & 
Brosschot, 2010; Vrany, Berntson, Khambaty, & Stewart, 2015). Therefore, depression 
may increase cardiovascular disease risk in racial/ethnic minorities by accelerating the 
development of allostatic load.        
The presence of social support has been shown to decrease cardiovascular disease 
risk and mortality (Berkman, Leo-Summers, & Horwitz, 1992; Cohen & Wills, 1985; 
Frasure-Smith et al., 2000; Treiber et al., 2003).  Two main hypothesis that have sought 
to explain this relationship. First, it is hypothesized that social support may exhibit 
independent effects on cardiovascular risk (House, Umberson, & Landis, 1988). For 
example, social support may decrease cardiovascular risk by facilitating healthy 
behaviors such as exercise, healthy eating, and adherence to medical treatment 
(DiMatteo, 2004; Franks, Campbell, & Shields, 1992; Lewis & Rook, 1999; Uebelacker 
et al., 2013)   Secondly, social support may buffer the relationship between depression 
and cardiovascular risk (Cohen & Wills, 1985; George, Blazer, Hughes, & Fowler, 1989). 
Higher family support has also been shown to lower the association between depression 
symptoms and stressors such as racial discrimination (Brody et al., 2006; Noh & Kaspar, 
2003; Uebelacker et al., 2013; Wei, Heppner, Ku, & Liao, 2010).    Moreover, the 
absence of support has been associated with the onset of depression both independently 
and through modifying perceptions of negative life events (Paykel, 1994). 
Allostatic load is widely accepted as a quantitative metric used to study the 
consequences of weathering, giving researchers the ability to measure both the acute and 
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long-term outcomes of the stress response. Measurement of allostatic load is based on a 
set of biomarkers that represent the current status of each physiological system that 
responds to stress (e.g. hypothalamic-pituitary-adrenal (HPA) axis, cardiovascular 
system, metabolic processes and the immune system).  An algorithm then computes 
allostatic load by demarcating clinical cut points to dichotomize continuous biological 
measurement into binary variables (0 = low risk, 1 = high risk). These values are then 
summed to yield an allostatic load score which determines the presence/absence of 
allostatic load. There are three important limitations to this approach.  First, clinical cut 
points may not capture the full extent biological risk.  Secondly, categorizing otherwise 
continuous data results in loss of valuable information captured by the variables used to 
calculate allostatic load. Third, it is improbable that each biomarker equally contributes to 
the calculation of an allostatic score.  Therefore this study sought to achieve the 
following aims and address the subsequent hypotheses.   
Specific Aims and Hypotheses 
Aim #1   
Apply Latent Profile Analyses (LPA) to continuous level biomarkers in the 
National Health and Nutritional Examination Survey (NHANES) data to segment the 
participants into a set of qualitatively distinct biological risk profile subgroups.   
Hypothesis 1a 
 Prior research using two-step cluster analysis on similar biomarkers in NHANES 
data yielded four biological risk profiles for Vascular Risk, Kidney Risk, Inflammatory 
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Risk, Cholesterol Risk, and Low Overall Risk (Johnson et. al., 2005). It is hypothesized 
that LPA will identify at least five profiles associated with cardiovascular risk.  
Hypothesis 1b 
 According to the weathering hypothesis, African Americans experience 
symptoms of biological weathering beginning in their 20s. However, there is no work to 
date which has looked at the impact of age on cardiovascular risk profiles. Thus in this 
exploratory hypothesis we anticipate that an increase in age will be associated with 
membership in higher risk profiles. 
Hypothesis 1c 
Cardiovascular risk has been shown to differ by sex. For example, African 
American men have been shown to have higher risk of kidney failure whereas African 
American women display higher risk of hypertension. Therefore it is hypothesized that 
males will more likely have membership in kidney risk profiles while females will hold 
membership in vascular risk profiles.   
Aim #2 
Expand upon the model in Aim 1 to examine the association between depression, 
social support and risk profile membership.  
Hypothesis 2a 
Evidence suggests a positive association exists between the severity of depressive 
symptomology and risk of cardiovascular disease, such that those with higher depression 
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scores are more likely to experience a cardiovascular event. Therefore, it is hypothesized 
that increased depression scores will be associated with membership in high risk profiles.  
Hypothesis 2b   
Prior research finds that social support may independently lower the risk 
cardiovascular disease. Social support has been shown to reduce cardiovascular reactivity 
to stress.  As such, it is hypothesized that social support will increase the probability of 
membership in a low risk profile. 
Hypothesis 2c 
 Social support has been shown to buffer the effects of stress, resulting in reduced 
cardiovascular risk.  This suggest that social support may moderate the relationship 
between stress and cardiovascular disease risk. Therefore, it is hypothesized that social 
support will moderate the relationship between depression and cardiovascular risk by 
reducing the odds of higher risk profiles.  
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   Figure 1. Overall Study Conceptual Framework
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CHAPTER II 
REVIEW OF THE LITERATURE  
 
 
Introduction to Cardiovascular Disease Epidemiology 
Cardiovascular Disease (CVD) is the leading cause of death in the United States 
(CDC, 2013). Though cardiovascular diseases encompasses more specific diagnoses, 
there are 5 major diagnoses that are discussed. Myocardial infarction, heart failure, 
coronary artery disease, stroke, and high blood pressure are prominent measures of CVD 
outcomes. Therefore, this literature review focuses on these five diagnoses as the frame 
for my discussion on racial/ethnic disparities in cardiovascular disease. Further, this 
review discusses racial/ethnic differences in traditional cardiovascular risk factors (e.g., 
lifestyle and genetics) as well as cardiovascular risk associated with endocrine and 
metabolic disorders. Lastly, I will provide a rationale for the use of the weathering 
hypothesis in accounting for the impact of psychosocial factors such as depression and 
social support on cardiovascular risk.  
Epidemiologic data in my discussion has been collected from numerous state and 
national databases in addition to epidemiologic research studies. The data presented focus 
primarily on racial ethnic differences in incidence, prevalence, all-cause mortality, age-
specific mortality, and age adjusted mortality.  I chose these measures of racial/ethnic 
difference in health indicators and outcomes based on the data available from these data 
sources. However, there is a need to discuss the methodological limitations of data
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collected for analysis as these sources may not accurately depict the extent of CVD 
disparities. 
 One important limitation is revealed when epidemiologic data does not account 
for the various age distributions within the different racial and ethnic groups. Age-
adjusted rates are the weighted average of age-specific rates in which the weights are 
determined by an age standard. In most cases, the age standard is the population 
distribution identified by United States Census.   However, racial/ethnic populations 
differ by age structure with Whites having an older median age than all racial and ethnic 
minorities. Therefore, age-adjusted rates are indices for comparison but cannot be risk 
measures (NCHS, 2004).  Use of age-specific data, as compared to age-adjusted, 
represents different patterning of death rates. For example, the all-cause age-adjusted 
death rate for African Americans is about 30% higher than that of Whites. However, age-
specific rates show that all-cause mortality for African Americans are about 75% higher 
than Whites (Thomson, Mitchell & Williams, 2006).  
Further, issues of external validity may arise when data does not account for 
intraethnic variation among subgroups.  Certain ethnic minorities such as Hispanics and 
Asian/Pacific Islanders may be grouped into large ethnic categories.  For example, 
Hispanics report higher incidence rates of CVD risk factors but exhibit lower rates of 
overall CVD (Mensah, 2005; Mitchell et. al., 1990; Liao et. al., 1997). Highest 
prevalence of hypertension and hypertension-related death rates were seen among Puerto 
Rican Americans compared to all Hispanic subgroups. Hypertension-related death rates 
were lowest among Cuban Americans.  Mexican Americans exhibited a higher 
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prevalence of hypertension and prehypertension compared to Whites. Analysis of 
Hispanic subgroups is needed to understand the CVD risk factors among Hispanics and 
other ethnic groups. Ignoring intraethnic variation among subgroups misses the 
opportunity to distinguish CVD risk within racial/ethnic groups.   
Frequently, mortality data is presented as all-cause versus cause-specific. Racial 
differences may go unrecognized based on presentation of epidemiologic data as all-
cause or cause-specific. One example of this is demonstrated by data that shows 
Hispanics as having a lower all-cause mortality rate than Whites but a higher cause 
specific mortality rates (Thomson, Mitchell, & Williams, 2006). Many CVD 
epidemiologic studies, many which are used in this paper, do not differentiate between 
all-cause mortality and cause-specific mortality rates. This c to incorrect inferences about 
CVD disparities among certain study populations.  Research suggest that, when available, 
use of age-specific and cause-specific rates provides a more accurate depiction of 
differential health statuses between groups (NCHS). 
Cardiovascular Disease and Outcomes 
Myocardial Infarction 
Each year 735,000 people experience a myocardial infarction (MI) in the United 
States.   Of these cases, 525,000 will suffer their first MI while 210,000 will be diagnosed 
with a recurrent MI.   (Mozaffarian et al., 2015). In 2013, MI was the cause of death for 
6,456 African American males compared to 6,004 African American females. Among 
women age 20 and older 1.8% of Whites have had an MI which is comparable to the 
Hispanic rate (1.7%).  However, this rate is elevated among African American women at 
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2.2%. MI incidence rates among African American (3.4%) and Hispanic men (3.5%) 
were comparable to one another but higher than rates of women.   
Coronary Heart Disease 
Coronary Heart Disease (CHD) is the leading underlying cause of MI.  
Approximately 370,000 people die each year from CHD (Mozaffarian et. al, 2015). In 
2011, CHD affected 15.5 million people over the age of 20 accounting for 6.2% of the 
population. Overall CHD prevalence differs by gender.  CHD prevalence among men was 
7.6% compared to 5.0% for women (Newman et. al., 2013). Prevalence is highest among 
White men (7.8%) but slightly lower for African American men (7.2%).  CHD 
prevalence among Hispanic men is 6.7%.  Among females, CHD prevalence was highest 
among African American women (7.0%).  CHD prevalence lowers to 5.9% for Hispanic 
women and 4.6% for White women (Newman et. al., 2013) 
CHD has an overall death rate of 109.2 per 100,000 causing 1 in 7 of all deaths in 
2011 (NHLBI, 2014).   African American men had the highest CHD death rate.   The 
death rate per 100,000 for African American males was 161.5 compared to 146.5 for 
White males. The death rate per 100,000 was higher for African American women (99.7) 
compared to White females (80.1) (NHLBI, 2014).  Incidence of fatal CHD has 
decreased between 1987 and 2011.  Fatal CHD decreased the most for White men (5%).  
CHD deaths decreased similarly for White (3.9%) and African American women (3.4).  
However, fatal CHD was reduced by only 2.2% for African American men.   
Though White men have a slightly higher prevalence of CHD than African 
Americans as a racial group, there are stark differences in CHD mortality. A study 
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conducted by Gebreab and Diez Roux (2012) sought to explain disparities in CHD 
mortality rates by examining spatial heterogeneity of African American and White 
differences in CHD mortality and the contributions of poverty and segregation. The 
authors found that African American and White differences in CHD was significantly 
related to spatial heterogeneity when controlling for poverty and segregation.  However, 
when accounting for race-specific poverty and segregation, heterogeneity no longer 
predicted differential mortality rates.  This suggest that though African American and 
White men may be similarly affected by CHD, issues associated with high density 
poverty areas for African Americans (i.e. lack of resources, quality of care) could be 
driving CHD mortality disparities.  
Heart Failure 
There were approximately 870,000 new cases of Heart failure each year from 
2005-2011 (Mozaffarian, 2015). Heart failure is more frequently seen in women and the 
elderly (Goldberg, Spencer, Farmer, Meyer, & Pezzella, 2005). After age 40, 1 in 5 men 
and women will developed Heart failure (Lloyd-Jones et al., 2010).  Research conducted 
by the Coronary Artery Risk Study in Young Adults (CARDIA) found that heart failure 
before age 50 years is more common among African Americans (Ovbiagele et al., 2013) 
According to Atherosclerosis Risk in Communities (ARIC) study, the age-adjusted 
incidence rate per 1000 person-years was highest among African American men (9.1).  
This was followed by African American women (8.1), White men (6.0) and White 
women (3.4).   
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 In 2011, heart failure was the underlying cause of 58,309 deaths with an overall 
any-mention death rate for Heart Failure of 83.0 (NCHS, 2011).  In the Multi-Ethnic 
Study of Atherosclerosis (MESA) study, African Americans held the greatest risk of 
heart failure of 4.6 per 1000 person-years. This was followed by Hispanic (3.5), White 
(2.4) and American Indian/Alaska Native (1.0) (Bahrami, 2008). Any mention death rates 
were similar among White and African American men with 98.5 and 98.6 respectively. 
The death rate per 100,000 was smaller for American Indians or Alaska natives (73.2) 
and Asians or Pacific Islanders (44.1). The death rate per 100,000 was similar for African 
American women (77.4) and White women (73.6).   Among American Indians/Alaska 
Natives women, the death rate was  61.9 per 100,000 compared to 33.9 per 100, 000 
Asian/Pacific Islanders women (Mozaffarian et al., 2015). 
Stroke 
Approximately, 795,000 people in the US suffer from a new or recurrent stroke. 
Approximately, 610,000 are first onset strokes while 185, 000 are recurrent strokes 
(NHLBI, 2011).    In 2010, 2.7% of men and 2.7% of women aged 18 or older have a 
history of stroke.  This number is almost doubled for African Americans (4%).  This is 
followed by non-Hispanic Whites of 2.5%, 2.3% of Hispanics, and 1.3% of Asian/Pacific 
Islander (Kleindorfer, 2010).  
By 2030, 3.4 million people over 18 years of age or older will have a stroke 
increasing the prevalence to 20.5% from the year 2012.   The highest projected increase 
in stroke prevalence is expected to increase by 29% among Hispanic men (Ovbiagele, 
2013).   Compared to data in 1990, stroke incidence in 2005 decreased for Whites but not 
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for African Americans. Stroke incidence among Whites was primarily driven by decline 
in ischemic strokes in this population.  There were no changes in ischemic stroke or 
hemorrhagic strokes for African Americans (Kleindorfer, 2010).    
Non-traditional risk factors may play a role in excess stroke risk leading to the 
largest projected increase in stroke prevalence among Hispanic men.  For example, 
Hispanics have lower health literacy, concerns for side effect medication, burden of 
filling prescriptions, a perceived racial bias from healthcare system which may influence 
receipt and compliant of treatment for traditional risk factors (Cruz-Flores et al., 2011). 
Cruz-Flores and colleagues (2011) also noted lower socioeconomic status (SES), limited 
healthcare access and use, and inadequate community resources among Hispanics may 
help to explain Hispanics increasing risk of stroke.   
Hypertension 
Approximately 33% of US adults age 20 and older have been diagnosed with 
hypertension from 2009-2012.    African American adults have the highest prevalence of 
hypertension.  Age-adjusted prevalence of hypertension among African American men 
and women during this time period was 44.9% and 46.1% respectively. Prevalence was 
lowest among those 18 to 39 years of age (7.3%) followed by those 40 to 59 years of age 
(32.4%). The highest prevalence was seen in people over 60 (32.4%) (Nwankwo, Yoon, 
Burt, & Gu, 2013).    More men than women have hypertension before age 45.   
However, among those aged 45-64, the percentage of men and women with hypertension 
is comparable. However, for those age 65 and older, the percentage of women with 
hypertension are higher than men (Nwankwo et al., 2013). 
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Overall the hypertension mortality rate was 110.0 per 100,000. From 2001-2011 
the mortality rate attributed to hypertension increased 13.2% (NCHS, 2011).  African 
American males had the highest mortality rate of 212.8 per 100,000 compared to 114.5 
per 100,000 for White males. Among African American females, rates were 157.9 per 
100,000 compares to rates of 92.00 per 100,000 for White females (Murphy, Xu, 
Kochanek, & others, 2013).   The age-standardized mortality rate per 100,000 among 
Hispanic females was 118.3 compared to Hispanic men (135.9) (CDC, 2013). 
Among all CVD’s, hypertension seems to be a major precursor of other CVDs.  
The highest prevalence in risk factors for African Americans seem to by hypertension 
and diabetes (Gillum, 1999; Kittner, White, Losonczy, Wolf, & Hebel, 1990; Kleindorfer 
et al., 2009).  For example, among  those who experience their first stroke, blood pressure 
was found to be above 140/90 while 75% of heart failure patients have hypertension 
(Kissela et al., 2012). African American adults have the highest incidence of 
hypertension in the US (Mensah, Mokdad, Ford, Greenlund, & Croft, 2005). Higher 
systolic blood pressure accounts for approximately 50% of the excess risk for African 
Americans compared to Whites (Kleindorfer et al., 2009). There are racial differences in 
levels of systolic blood pressure.  For every 10 mm Hg increase in systolic blood 
pressure, stroke risk increased among White approximately 8%. However, African 
Americans experience, a 24% increased risk of stroke with each increase of 10 mm Hg 
(Howard et al., 2013).   African Americans and Mexican Americans have higher blood 
pressure but have been shown to have lower blood pressure control in the US (Redmond, 
Baer, & Hicks, 2011). 
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Cardiovascular Disease Risk Factors 
Lifestyle Factors 
Evidence points towards racial differences in life style risk factors as potential 
contributor to CVD disparities.  Risk factors for CVD seem to have a larger impact on 
minorities than for Whites (Howard et al., 2013).   Poor diet quality has been attributed to 
678,000 annual deaths of all- causes in US. Fruit and vegetable consumption is lowest 
among African Americans with an average range of 2%-6% meeting the 2 cup 
requirement for both fruits and vegetables.    Among Whites this range was 9-12% and 
among Hispanics 4%-11%.  
 In the Reasons for Geographic and Racial Differences in Stroke (REGARDS) 
study, participants who reported physical activity less than 4 times a week demonstrated a 
20% increase risk of stroke compared to those who exercised over 4 times a week 
(McDonnell et. al, 2013).    According to the 2013 National Health Interview Survey, 
women were less likely to meet the guidelines of at least 150 minutes of moderate 
physical activity or 75 minutes of vigorous physical activity per week. African 
Americans and Hispanics were also less likely to be physical active. 41.4% of African 
Americans and 42.9% of Hispanics met the aerobic activity guidelines, compared to 
53.4% of Whites (NCHS, 2013).   Lowest fitness (physical activity and nutrition) levels 
have been seen among African Americans (Kurian & Cardarelli, 2007; Carnethon, Gulati, 
& Greenland, 2005). 
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Overweight and Obesity 
Low fitness levels have been associated with overweight and obesity (Blair & 
Church, 2004). Overweight and obesity was a risk factor for CVD for all ages, sexes, and 
racial and ethnic groups (Kurian & Cardarelli, 2007; Roger et. al., 2011).   Overall, 69% 
of US adults were overweight or obese.   For men, Hispanics (80%) and Whites (73%) 
were more likely to be overweight or obese compared to African American men (69%). 
For women, African Americans (82%) and Hispanics (76%) were more likely to be 
overweight or obese compared to Whites (61%) (Mozaffarian, 2015).  Further, data from 
the Framingham Heart study indicates that obesity (BMI greater than 30 kg/m) has been 
driving rapid increases of diabetes diagnoses within the last 30 years (Fox et. al, 2006). 
Diabetes 
Diabetes increases the incidence of stroke for all ages. Patients diagnosed with 
stroke and diabetes are more likely to be African American. However, the risk of stroke 
is the most prominent before age 65 among both African American and White patients 
(Khoury et. al., 2013). The prevalence of total diabetes in 2013 among African 
Americans (15.4%) is twice that of Whites (8.6%) but only slightly higher than Mexican 
Americans (15.2%) (Selvin, 2014). The prevalence of diabetes is expected to increase by 
127% among Hispanics, 107% among African Americans, and 99% among Whites. The 
largest increase is projected among African Americans over 75 years old (606%) 
(Narayan, 2006). 
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Metabolic Syndrome 
Metabolic syndrome is a group of lifestyle related cardiometabolic risk factors 
associated with obesity and insulin resistance.   Metabolic syndrome has been linked to 
left ventricular dysfunction, even when controlling for blood pressure (Ingelsson, et. al., 
2006). Metabolic syndrome is diagnosed when individuals exhibit 3 of 5 risk factors: 
Fasting plasma glucose over 100 mg/dL or prescription for elevated glucose; HDL 
cholesterol less than 40 mg/dL for men and less than 50 mg/dL in women, waist 
circumference over 102 cm for men and more than 88 cm for women, and blood pressure 
over 130/85 mmHg diastolic or on medication for elevated blood pressure (Alberti et. al., 
2009).    
 Overall, the age-adjusted prevalence of metabolic syndrome has decreased for 
women but remained stable for men. In 2000, age-adjusted prevalence was 27.50% of 
women and 23.35% of men.  In 2010, the age adjusted prevalence was 23.69 for men and 
21.80% for women (Beltrán-Sánchez, 2013). Reduced metabolic syndrome has been 
observed primarily among Whites but has remained stable for both African Americans 
and Mexican Americans.  The age adjusted prevalence for metabolic syndrome in 2010 
was highest among Hispanic men (34.76) compared to White men (21.77) and African 
American men (18.99). Research shows that metabolic syndrome and insulin resistance 
are significant risk factors for heart failure among Hispanics in US.  Compared to all 
other racial/ethnic groups, Mexican Americans have the highest age-adjusted prevalence 
of metabolic syndrome (Ford, Giles, & Dietz, 2002).         
 
 
20 
 
Genetics 
Genetic factors associated with heart disease are complex. The link between 
specific genetic pathways are not well of established past that of establishing family 
history (Holmes et. al., 2011).  Among adults over 20 years of age, approximately 12% 
have reported a parent or sibling diagnosed with angina or a myocardial infarction before 
age 50 from 2009-2012 (Mozaffarian, 2015).  Stratified by race and ethnicity, 11.5% of 
White men and 14.6 of White women reported having a parent or sibling diagnosed with 
angina or myocardial infarction. This was followed by 9.1% of African American men 
and 12.3% of African American women as well as 7.6% of Hispanic men and 10.1% for 
Hispanic women (10.1%).  Paternal history of myocardial infarction before age 50 has 
been found to increase risk approximately 50% among women and 70% among men 
(Lloyd-Jones, 2004).  Sibling history of CVD was found to increase the odds of CVD 
approximately 45% when controlling for other CVD risk factors (Murabito, 2005). 
Depression 
Depression and cardiovascular disease are the two of the most common causes of 
disability across the world (Murray & Lopez, 2013).    Evidence suggests there is a 
complex and bidirectional relationship between cardiovascular disease and depression  
(Lippi et al., 2009).  One out of every five patients with cardiovascular disease will 
experience a major depressive disorder (Thombs et al., 2006). Depression not only 
worsens cardiovascular disease prognosis but it increases overall mortality from 
cardiovascular disease  (Barth et al., 2004; Ferketich et al., 2000; Frasure-Smith et al., 
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2000, 2000; Lett et al., 2004; Van Melle et al., 2004). Yet, the pathway for the complex 
interplay between depression and cardiovascular disease remains unexplained. 
Increasing evidence suggests that depression may serve as an antecedent for a 
number of cardiovascular diseases including coronary artery disease, coronary heart 
disease, myocardial infarction (Barefoot & Schroll, 1996; Charlson et al., 2011; Ferketich 
et al., 2000; Keyes, 2004; Van der Kooy et al., 2007). Psychosocial factors have been 
shown to increase the risk of cardiovascular disease more so than traditional risk factors 
(e.g. hypertension, diet, exercise) (Joynt et al., 2003; Kim & Setias, 2016; Lett et al., 
2004).  A study conducted by Yusuf and colleagues (2004) found that psychosocial 
factors such as perceived stress, negative life events, and depression were stronger risk 
factors for cardiovascular disease than diabetes, smoking, hypertension, and obesity. On 
the premise of this study and other studies examining the global burden of cardiovascular 
disease, the 2010 Global Burden of Disease study recognized depression as a recognized 
risk factor for coronary heart disease (Charlson et al., 2011).   A positive association has 
been observed between the severity of depressive symptomology and the odds of 
cardiovascular disease (Barefoot & Schroll, 1996; Charlson et al., 2011).  This 
relationship may be additive in nature as existing literature finds that traditional 
cardiovascular risk factors may strengthen the association between depression and 
cardiovascular disease risk (Rugulies, 2002).   
  National data suggests that the rate of depression diagnosis is increasing across all 
races and ethnicities. A study examining data from the National Ambulatory Medical 
Care Survey from 1992-1993 to 2003-2004 found depression diagnoses rose from 4.8 to 
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7.0 per 100 for Hispanics, 4.2 to 7.6 for African Americans and 10.9 to 15.4 for whites 
(Sclar, Robison, & Skaer, 2008). Although Whites exhibit higher depression diagnosis, 
the burden of depression is higher among minorities.  In a national epidemiological study 
of mental health and service usage, 63.7% of Latinos and 58.8% of African Americans 
lacked access to mental health treatment compared to 40.2% of Whites (Alegría et al., 
2015; Williams et al., 2007). Further, African-Americans have been shown to have the 
highest rate of severe depressive symptoms and suffer with depression over a longer 
period of time (Pratt & Brody, 2014; Williams et al., 2007). These findings suggests 
minorities often have an increased burden of severe depressive symptoms disability even 
though Whites have a higher prevalence of depression.   
Disparities in depression diagnoses are apparent early in the lifespan as evidence 
suggests that racial/ethnic minority adolescents have higher rates of depressive symptoms 
and limited access to treatment.  In a study comparing white and Hispanic youth, Whites 
(36%) were significantly more likely than Hispanics (27%) to receive adequate mental 
health (Alexandre, Martins, & Richard, 2009). Further, Cummings and colleagues used 
data from the National Survey on Drug Use and Health to examine racial/ethnic 
differences in mental health services for White, African American, Hispanic, and Asian 
adolescents. Results of the study showed that when accounting for family income and 
insurance status, African American, Hispanic, and Asian adolescents were significantly 
less likely than Whites to receive prescription medication for depression, receive 
treatment from a health care provider, or receive outpatient mental health treatment 
(Cummings & Druss, 2011).  
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Social Support 
The presence of social support has been shown to decrease cardiovascular disease 
risk and mortality (Berkman et al., 1992; S. Cohen & Wills, 1985; Frasure-Smith et al., 
2000; Treiber et al., 2003). Two main hypothesis have sought to explain this relationship. 
First, it is hypothesized that social support may exhibit independent effects on 
cardiovascular risk (House et al., 1988). For example, social support may decrease 
cardiovascular risk by facilitating healthy behaviors such as exercise, healthy eating, and 
adherence to medical treatment (DiMatteo, 2004; Franks et al., 1992; Lewis & Rook, 
1999; Uebelacker et al., 2013)   Secondly, social support may buffer the relationship 
between of depression and cardiovascular risk (S. Cohen & Wills, 1985; George et al., 
1989). Higher family support has also been shown to lower the association between 
depression symptoms and stressors such as racial discrimination (Brody et al., 2006; Noh 
& Kaspar, 2003; Uebelacker et al., 2013; Wei et al., 2010).    Moreover, the absence of 
support has been associated with the onset of depression both independently and through 
modifying perceptions of negative life events (Paykel, 1994).  
Weathering Hypothesis 
Though the risk factors discussed above contribute to CVD disparities, they do 
not fully account for racial disparities in CVD outcomes.  Over the past twenty years, 
research has been conducted on the impact of race based stressors on health (Krieger, 
1990; Geronimus et. al., 2006; Mwendwa et al., 2011). Though this is not a new area of 
research, the need for further inquiry lies in the continual need to understand health 
outcomes beyond individual level factors (i.e., physical activity, nutrition).    This is 
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particularly true when attempting to understand the development and persistence in CVD 
disparities among minorities, particularly African Americans. 
The weathering hypothesis, developed by Geronimus (2000), posits that stress 
associated with racial inequities may cause health deterioration among African 
Americans as early as young adulthood.  The weathering hypotheses was developed in 
response to observed racial differences in health outcomes among young women that 
were exacerbated across age.  More specifically, in a study of hypertension prevalence 
among women of childbearing age, African American and White differences in 
hypertension prevalence were unobserved among teenagers. However, by their mid-20’s, 
African American women were twice as likely as White women to be hypertensive 
(Geronimus, 1991).  Geronimus asserts that differential age pattern of health 
disadvantages among African Americans may represent the process of biological 
weathering (Geronimus, 1991; Geronimus, 2001).   
The impact of broad economic, social, and structural inequities based on race 
have been shown to impact the health of Africans Americans more so than their White 
counterparts (Geronimus, 2004).  The weathering hypothesis theorizes that minorities 
experience repeated exposure to subjective (discrimination) and objective stressors (job 
security, financial strain), resulting in increased engagement of chronic active coping.  
Active coping is defined as taking a problem focused action toward reducing stressful 
conditions (Carver & Scheier, 1994, James, 1994)).  Geronimus asserts that chronic 
active coping with stressors such as discrimination can lead to physiological 
deterioration. 
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Allostatic Load 
Active coping has been shown to have deleterious effects on health (James et. al., 
1992; McEwen, 1998).Though there has not been a direct measure of weathering, 
researchers have used indices such as infant mortality, disability, and mortality that reveal 
an aging pattern among African Americans that is consistent with the premise of the 
weathering hypothesis (Geronimus, 2000; Geronimus et. al., 2001, Astone, Ensminger, & 
Juon, 2002). For example, Geronimus and colleagues examined telomere length among 
women in the Women’s Health across the Nation (Swan). Telomeres are stabilizing caps 
on chromosomes that shorten during cell division resulting in cell aging or death. An 
inverse relationship between telomere length and age has been found (Benetos et al., 
2001). The authors found that between the ages of 49-55, African American women were 
7.5 years biologically older than White women (Geronimus et. al., 2010).    
Though different indices have been used to examine the process of weathering, 
the most commonly used indicator of weathering is allostatic load (AL).  When 
individuals experience acute and chronic stressors, physiological consequences occur 
from neglecting internal need (McEwen & Stellar, 1993). During the stress response, 
internal physiological needs are suppressed to combat external stressors. The major 
physiological systems that adapt to stress are the sympathetic nervous system, 
hypothalamic-pituitary-adrenal axis (HPA), metabolic system, and the immune system.  
These physiological systems are responsible for adapting to external stressors such as 
danger, hunger, or infection (McEwen, 1998). When individuals experiences acute and 
chronic stressors, physiological consequences occur resulting from neglected internal 
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need (McEwen & Stellar, 1993). This physiological consequence is considered allostatic 
load. As a result, physiological systems lose the ability to adapt to future stressors 
(Seplaki, Goldman, Weinstein, & Lin, 2004). 
Measuring allostatic load requires assessment of biomarkers associated with each 
physiological system.  There are four primary hormones that are released in response to 
stress; cortisol, noradrenalin, epinephrine, and dehydroepiandrosterone-sulfate (DHEA-
S). These hormonal mediators influence the release of other physiological hormones in 
the body. For example, cortisol is a glucocorticoid that provides various effects on the 
body from energy metabolism to transporting immune cells (McEwen & Seeman, 1999).  
Most allostatic load calculations measure secondary outcomes associated with the effects 
of primary mediators. For example, waist to hip ratio and glycated hemoglobin reflects 
sustained levels of glucose and insulin resistance which portrays sustained levels of 
cortisol and sympathetic nervous system activity.   Other indicators such as blood 
pressure and heart rate are indicators of overall cardiovascular activity. Allostatic load 
has been associated with increased risk of cardiovascular disease (Geronimus et al., 2006; 
McEwen & Seeman, 1999; Seeman et al., 1997). Compared to Whites, African American 
experience higher allostatic load scores earlier in life. Further evidence suggests that 
African American women experience allostatic load earlier in life. Chyu and Upchurch () 
found that African American women age 40-49 years of age had allostatic load scores 
1.14 times higher than White women 50-59 years of age scores (Chyu & Upchurch, 
2011). Higher allostatic load scores have been associated with a decline in physical and 
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cognitive functioning, cardiovascular disease incidence, and mortality (Geronimus et al., 
2006; McEwen & Seeman, 1999; Seeman et al., 1997).  
Weathering Hypothesis Examined 
Geronimus used data available from the 2003-2006 National Health and 
Nutritional Examination Survey (NHANES) to conduct a population based study of 
weathering among African American and white women. She selected 10 biomarkers to 
include in her calculation of allostatic load; Systolic and diastolic blood pressures, body 
mass index (BMI), Glycated hemoglobin, albumin, creatinine clearance, triglycerides, C-
reactive protein, homocysteine, and total cholesterol. Each biomarker was given a high 
risk threshold based on the distribution of the biomarker within the NHANES sample. 
For albumin and creatinine clearance, the high risk threshold was set at the measurement 
that represented the 25th percentile. For other biomarkers, measurements were set at the 
75th percentile. Each biomarker with measurements beyond each threshold received a 
point with a maximum score of 10.  Participants who were taking medication for 
diabetes, hypertension, and cholesterol was given a point for glycated hemoglobin, blood 
pressure, or total cholesterol if their respective biomarkers did not meet the high risk 
threshold.  The high risk value for allostatic load score was 4. To test the weathering 
hypothesis, mean scores were calculated based on age categories (18–24, 25–34, 35–44, 
45–54, and 55–64 years). Geronimus also subdivided African American and White 
samples by measures of socioeconomic status.   Geronimus and colleagues found that 
allostatic scores for African Americans were significantly higher than Whites for each 
age category.  African Americans had a higher probability of a high score (≥4) than 
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Whites at all ages. Also African American women had the greatest probability of a high 
allostatic load score.  
Secondly, the estimated odds of African Americans 18-24 years old having a high 
allostatic score was 1.49 times higher than Whites.   For those aged 55-64, the odds of 
African Americans having an allostatic load score increased to 2.31 times that of Whites.  
By the time African American women were 45 years old, 50% of African American 
women had a high allostatic score. However, by 64 years old, more than 80% of African 
American women exhibited an allostatic high score. Fifty percent of white men and 
women reached allostatic load around 60 years old. Whites were not seen to reach levels 
much above 60%. For African American and white women, the odds were more 
pronounced. The estimated African American-White odds per age category was as 
followed:  35–44 years (2.24); 45–54 years (2.23), and 55–64 years (2.73). The relative 
odds of African American women between the ages of 55-64 having a high allostatic 
score was twice that of African American men.     
Limitations of Approach 
Geronimus’ calculation of allostatic load requires dichotomizing 
continuous biological measurements into low and high risk categories. There are several 
limitations of categorizing continuous variables.  Two major drawbacks are the use of 
clinical cut points that are not universally applicable (across sex, race and time) and loss 
of information (Altman et al., 1994, Royston et al., 2006). Geronimus’ work suggests that 
African American women experience physiological deterioration earlier in life compared 
to White women. Therefore, a clinical cut point of 4 may be appropriate for White 
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populations but may not be the best indication of physiological breakdown among 
African American women.  There may also be need for the age appropriate clinical cut 
points for African American women as the weathering hypothesis suggest African 
American woman age earlier than other populations.  
Preliminary Cluster Analysis 
Using data from the 2013-2014 National Health and Nutrition Examination 
Survey (NHANES), a cluster analysis was conducted using the following 8 biomarkers 
similar to the ones utilized in Geronimus’ article:  Triglyceride; C-reactive protein; 
Albumin, homocysteine; total cholesterol; HDL; LDL and Creatinine clearance (Johnson, 
2015).   A two-step cluster analysis was employed using the standardized Z-scores of 
each biomarker in order to provide standardization of biomarkers with various units of 
measure.   Results of this 2-step cluster analysis yielded 5 distinct risk profiles (see 
Figure 2). 
Cluster 1: Vascular Risk Profile  
Cluster 1 exhibited elevated levels of homocysteine and albumin.  Homocysteine 
is an amino acid within blood plasma.  Albumin is a plasma protein, formed in the liver. 
Albumin constitutes approximately 6-8% of the protein concentration in the plasma. 
There is a relationship between homocysteine and albumin.  Jagger and colleagues 
(2001) found that increases in homocysteine levels was associated with increase in 
albumin levels. Further, increases in albumin levels and homocysteine levels were 
associated with increase arteriosclerotic risk (Lee, et. al., 2006). 
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Figure 2.  Preliminary Cluster Analysis 
 
 
 
Cluster 2: Kidney Risk Profile  
This profile consists of elevated levels of creatinine which is a key indicator of 
kidney functioning.  Chronic kidney function is a major risk factor for all-cause 
mortality and cardiovascular disease. Chronic kidney disease in more pronounced in 
African American populations (Wiener et. al, 2004).  Kidney disease also increases risk 
for hypertension and dyslipidemia. Further, hypertension and dyslipidemia can increase 
the progress of renal failure (Han et. al., 2007). 
Cluster 3: Inflammatory Risk Profile  
This profile consist of elevated levels of C-reactive protein which indicates the 
presence of inflammation and associated with progression of atherosclerosis (Ridker 
et.al, 2000).  It has been shown to be an independent indicator of cardiovascular events 
even when LDL levels are not elevated (Mendell, 1996). 
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Cluster 4: Low Overall Risk Profile  
In this profile, no biomarker shows any distinguished difference and the levels 
are relatively low on all biomarkers. This profile group consisted of our reference group 
in which I compared the other risk profiles when conducting multinomial regression.   
Cluster 5: Cholesterol Risk Profile  
In this profile, LDL and triglycerides are elevated suggesting cholesterol risk. 
Research has been conducted on the joint effect of triglycerides and LDL cholesterol 
levels on cardiovascular risk outcomes (Manninen et. al., 1992).   For example, the 
Helsinki Heart Study examined dyslipidemic middle aged men.   In this study, the 
relative risk of a cardiac event with a ratio of LDL to HDL greater than 2.4 mmol/l 
compared to those with ratio less than 2.3 mmol/l was 3.8. This suggests that increases 
of LDL cholesterol is related to cardiovascular disease risk outcomes.  
Study Significance 
The goal of this project is to expand upon Geronimus’ weathering hypothesis in 
several ways. First, current measurement of the variable allostatic load requires 
dichotomizing continuous biological measurements into low and high risk categories 
(yes/no) to construct a composite allostatic load score. Categorizing otherwise 
continuous-level data results in loss of information and independent effects otherwise 
captured by the variables used to calculate allostatic load (Altman et. al. 1994; Cohen, 
1983).   Further, calculation of an allostatic load score requires the use of clinical cut 
points for clinical biomarkers to determine high and low allostatic load risk.  Clinical cut 
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points may not be universally applicable to all subjects and do not account for clinical 
values that may fall into either high or low risk categories (Royston et. al, 2006).   
In addition, examining allostatic load as composite score for dichotomization 
(yes/no) presents challenges in determining if a specific biomarker is driving allostatic load 
scores. That is to say, in this scoring process, cases may be categorized as having AL for 
very different profiles of biomarkers which could indicate very different metabolic profiles. 
As noted above, preliminary cluster analysis of NHANES data set yielded five qualitatively 
distinct biological profiles. Specific psychobiological response patterns are necessary to 
adapt to specific threats which may require different outcomes (McEwen & Stellar, 1993). 
Research suggests that the HPA axis is not universally activated in response to all negative 
stressors.   Increased HPA activity is linked to specific stressors (Blascovich & Mendes, 
2000; Dickerson & Kemeny, 2004).  Preliminary cluster analysis revealed an inflammatory 
risk profile that consisted of elevated levels of C- reactive protein.  Activation of the HPA 
axis in response to stress has been shown to increase inflammatory activity similar to that 
seen when a foreign pathogen enters the body (Watkins, Nguyen, Lee, & Maier, 1999). 
Dickerson and colleagues (2004) conducted a study to examine the relationship between 
psychological stress and inflammatory activity. Participants were randomly assigned to a 
self-blame condition or a neutral control group.  Those in the self-blame condition reported 
increased shame and guilt compared to any other emotion but also exhibited increased 
proinflammatory cytokine activity. No changes in proinflammatory cytokine activity were 
seen in the control condition. This suggest that specific psychosocial stressors may increase 
proinflammatory cytokine activity and subsequent inflammation (Dickerson, Kemeny, 
 
33 
 
Aziz, Kim, & Fahey, 2004). These study findings also suggest the importance of 
identifying particular drivers of allostatic load.
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CHAPTER III 
 
METHODS 
 
 
Participants 
 
We utilized data from the 2005-2006 National Health and Nutritional 
Examination Survey (NHANES) collected by the National Center for Health Statistics. 
NHANES collects national data from both interviews and examinations. The interview 
portion also collects data on demographics, socioeconomic status, diet, and health 
outcomes.   The examination portion collects medical, dental, physiological 
measurements, and laboratory data.   NHANES employs a stratified multistage 
probability sample that represents the United States population for civilian, 
noninstitutionalized individuals. Thus, in addition to the breadth of data collected, the 
nation probability sample was also a major advantage to this study.  
Respondents who self-identified as Mexican, Other Hispanic, Non-Hispanic 
African American, Non-Hispanic White, and other race including Multi-Racial were 
recruited for participation in NHANES. Oversampling of individuals aged 60 and older, 
African Americans, and Hispanics allowed for an increase in the reliability of statistical 
analysis. NHANES provided a weighting variable to compensate for oversampling.
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Procedure 
Given that this study was designed to provide an alternative approach to the 
traditional allostatic load algorithm, we conducted a latent profile to develop 
cardiovascular disease risk profiles. On the premise of existing research examining 
biomarkers of stress and the data availability, 7 biomarkers were selected for inclusion in 
a latent profile analysis; C-reactive protein, total cholesterol, glycohemoglobin, 
homocysteine, albumin, creatinine clearance, and triglycerides were collected via 
participant blood samples.  Latent profile analysis (LPA) was used to develop risk profile 
categories. LPA is conceptually similar to cluster analysis as this analysis assigns 
individuals to mutually exclusive subgroups (classes) based on a set of “indicator” 
variables.(Masyn, 2013; B. Muthén, 2006)  LPA is a special case of Latent Class 
Analysis (LCA) in which the indicators are continuous as opposed to categorical.  Unlike 
LCA, LPA does not assume local independence which limits the possibility of covariance 
among indicator variables used in latent profile models.   Thus, use of LPA allows for 
flexibility in the structure of the classes in regards to the means, variances and 
covariances of the indicator variables.  The default in LPA is that the means of the 
indicator variables are free to vary across classes (thus resulting in different profiles 
across classes).   In addition, one may allow the variances and covariances of the 
indicator variables to be either invariant or unrestricted across classes.  The specification 
of the means structure can have a significant impact on the number and characteristics of 
the classes. 
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Statistical Approach 
A conservative approach was adopted in the development of the model class 
structure. First, each biomarker was transformed into standardized Z-scores based on raw 
data to account for different units of measurements among each biomarker.  Many of the 
biomarkers exhibited a highly positive skew. To our knowledge, there are no strong 
recommendations regarding the impact of skewness on latent profile analysis.  Therefore 
we adopted a systematic approach for trimming the raw data.  We established three levels 
of trimming at the 99th percentile, 97th percentile and the 95th percentile.  Using the raw 
data and the three levels of trimming we estimated a series of LPA models ranging from 
2 – 7 classes. Models with untrimmed data often did not converge thus creating rationale 
for utilizing trimmed data. We also allowed variable correlation within classes during 
model development.  Identification of an ideal number of classes was determined through 
a series of steps.    
First, we adopted the assumption that the pattern of means held unrestricted 
variance across classes (this is the default assumption in LPA).  Second, because the 
formula for computing total cholesterol incorporates some portion of the triglycerides 
value, we allowed total cholesterol and triglycerides to covary across all classes with the 
restriction that this covariance was invariant across classes.  Third, we allowed the 
variances and the pattern of variance among the indicator variables to vary across classes.   
Using Mplus version 7, (Muthén & Muthén, 2012) changes across the number of 
classes were examined in respect to the following fit indices; Akaike Information 
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Criterion (AIC), Bayesian Information Criterion (BIC), and the Sample Size Adjusted 
Bayesian Information Criterion (SS-BIC).  Secondly, we employed the Lo-Mendell-
Rubin (LMR) test to determine the appropriateness of K versus K+1 number class. We 
were unable to employ the bootstrapped LMR as NHANES utilizes sample weights.  
Lastly, we examined the distribution of cases across each class to identify symmetry 
within the latent profile model (Masyn, 2013).   Determining case distribution across the 
classes are important to determine whether the distribution of cases follow a normal 
distribution.   Multinomial logistic regression analysis was used to determine odds of risk 
profile membership for race (African American, White, Hispanic), sex, age and family 
income to poverty ratio.   
Variables and Measures 
C-reactive Protein (CRP) 
CRP is a protein released in an acute response during an inflammatory event. 
Increased levels of CRP detect the presence of disease and support differential diagnoses 
(Rosalki, 2001). Moreover, raised levels of CRP are also indicative of a poor prognosis 
among patients who present with symptoms related to a cardiovascular event.  There have 
been a wide range of prospective epidemiological studies that suggest that CRP is a 
robust indicator of cardiovascular events among patients with no prior cardiovascular 
disease (Hackam & Anand, 2003; Harris et al., 1999; Ridker, 2003; Ridker, Buring, Shih, 
Matias, & Hennekens, 1998; Ridker, Hennekens, Buring, & Rifai, 2000). Further, CRP 
levels have a long-term predictive value of a cardiovascular event such that increased 
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cardiovascular risk is present  20 years after an initial CRP recording was obtained 
(Sakkinen et al., 2002).  Values of CRP are reported as mg/dL in NHANES 2005-2006. 
Albumin 
Albumin is a protein produced by the liver that is essential to tissue growth and 
repair.   Low albumin levels have been associated with poor health outcomes and 
increased risk of mortality (Corti, Guralnik, Salive, & Sorkin, 1994; Reuben et al., 2000; 
Sahyoun, Jacques, Dallal, & Russell, 1996). Further, low concentrations of albumin have 
increased risk of cardiovascular disease (Gillum & Makuc, 1992; Horwich, Kalantar-
Zadeh, MacLellan, & Fonarow, 2008). Albumin has been shown to have an inverse 
relationship with CRP as Albumin is a negative acute phase protein that decreases in 
response to inflammation (Iwata, Kuzuya, Kitagawa, & Iguchi, 2006).  Values of albumin 
are reported as g/dL in NHANES 2005-6. 
Homocysteine 
 The link between homocysteine and cardiovascular diseases was first revealed in 
patients who were born with dysfunction in homocysteine metabolism and subsequent 
hyperhomocysteinaemia (Wald, Law, & Morris, 2002). Hyperhomocysteinaemia has 
been shown to increase the risk of stroke, heart disease, stroke, and atherosclerosis 
(Arnesen et al., 1995, 1995; Nygard et al., 1995).  Further, artery wall thickening, a 
common precursor to cardiovascular disease, has been associated with increased levels of 
homocysteine (Hankey & Eikelboom, 1999).  Values of homocysteine are reported as 
mg/dL in NHANES 2005-6. 
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Triglycerides 
 
Triglycerides are a form of excess energy or fats that exist within the body.   
Excess plasma triglycerides have been associated with cardiovascular disease, 
particularly coronary artery disease. Elevated levels of plasma triglycerides have been 
shown in those who are obese or overweight and consume a diet high in carbohydrates. 
Further, triglycerides have been associated with all-cause cardiovascular risk and 
mortality (Nordestgaard & Varbo, 2014).   Values of triglycerides are reported as mg/dL 
in NHANES 2005-6.   
Total Cholesterol 
 
Total cholesterol is measured by adding values for high density lipoprotein 
(HDL), low density lipoprotein (LDL) and 20% of the triglyceride level. HDL is 
considered the “good” cholesterol because research reveals that cardiovascular disease 
such as atherosclerosis are inversely related to level of HDL.  Further, LDL has been 
coined the “bad” cholesterol. LDL has been shown to contribute to plaque buildup and 
subsequent cardiovascular disease.   Individual with high triglycerides usually exhibit 
high overall total cholesterol. Elevated levels of total cholesterol has been shown to be a 
strong predictor of CHD, particularly among men (Carroll, Kit, Lacher, & Yoon, 2013; 
Peters, Singhateh, Mackay, Huxley, & Woodward, 2016). Values of total cholesterol are 
reported as mg/dL in NHANES 2005-6 
Glycohemoglobin 
Glycohemoglobin, estimated by a percentage of hemoglobin A1c, reflects the 
level of glucose in the blood.   Glycohemoglobin has been linked to vascular 
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complications which contributes to subsequent cardiovascular disease events. Further, 
glycohemoglobin has also been useful in detecting risk for incident cardiovascular events 
(Khaw et al., 2004; Meigs, Nathan, D’Agostino, & Wilson, 2002; Park, Barrett-Connor, 
Wingard, Shan, & Edelstein, 1996). Values of glycohemoglobin are reported as ‘ % of 
Hemoglobin A1C’ in NHANES 2005-6. 
Creatinine 
Creatinine serves as a measure of glomerular filtration. Elevated levels of 
creatinine indicate the presence of acute and chronic renal insufficiency and/or urinary 
obstruction.   Further chronic kidney disease has been shown to significantly increase the 
risk of cardiovascular disease. However, there has been evidence that suggest that this 
increase could be a result of pre-existing subclinical vascular disease (Weiner et al., 
2004). Values of Creatinine are reported as mg/dL in NHANES 2005-6. 
Risk Profile Membership 
The independent variable for this study is risk profile membership.  Risk profile 
membership will be developed through Latent Profile Analysis (LPA) of the variables 
commonly used to examine allostatic load (discussed in more detail in analysis).  
Examining allostatic load requires measurements that represent the major physiological 
systems that are activated during a stress response.   These systems include the 
sympathetic nervous system, hypothalamic-pituitary-adrenal axis (HPA), metabolic, and 
immune system. Therefore the following biomarkers at baseline will be used to determine 
risk profile membership. 
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Depression 
The PHQ-9 (α =0.89) is a 9 item depression scale that establishes criteria for 
depression diagnosis and rates the severity of depressive symptoms (Kroenke & Spitzer, 
2002).  This scale consist of 9 questions that measure the frequency of depressive 
symptoms (e.g.  little interest in doing things, feeling down depresses, or hopeless; 
difficulty these problems have caused) within the past 2 weeks.  Frequency was assessed 
on a scale of 0-3 with 0 indicating rarely experienced and 3 indicating a symptom was 
experienced most to all of the time. Higher PHQ-9 scores indicated a higher frequency 
and severity of symptoms.  The PHQ-9 is a shortened version of the primary care 
evaluation of mental disorders (PRIME-MD®) used for assisting health providers in 
determining criteria based diagnoses (e.g. mood, anxiety, alcoholism) commonly faced 
among medical patients (Spitzer et al., 1994).  The PHQ-9 is a self-administered three 
page version of the PRIME-MD® with a comparable sensitivity (65%-95%) and 
specificity (85%-95%) of lengthier depression scales (Kroencke, Spitzer, & Williams, 
2001).   
Social Support 
 Emotional support, financial support, and social network were assessed using 
social support questions collected in NHANES. Emotional support was measured by 
participants’ response to the question, “Can you count on anyone to provide you with 
emotional support such as talking over problems or helping you make a difficult 
decision?” Financial support was measured by participants’ responses to, “If you need 
some extra help financially, could you count on anyone to help you; for example, by 
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paying any bills, housing costs, hospital visits, or providing you with food or clothes?”  
Emotional and financial support were coded into a binary variables in which participants 
either received a “1” when answering “yes” or a “0” when answering “no”.  Social 
network was measured by participants’ responses to the question “how many close friend 
do you have”. Close friends were defined as relatives or non-relatives that participants 
felt at ease with, could talk to about private matters, and who they believed they could 
call on for help. Participants’ responses could range from 0-50 friends    
Family Income Poverty Ratio 
The family income poverty ratio is calculated by dividing family income, specific 
to family size, by the poverty guidelines set forth by the Department of Health and 
Human Services (HHS).  These guidelines are used to determine eligibility for federal 
assistance programs such as the Supplemental Nutrition Assistance Program (SNAP), 
Special Supplemental Nutrition Program for Women, Infants, and Children (WIC), and 
the National School Lunch Program. Sampling weights as provided by NHANES were 
also employed.  
Body Mass Index (BMI) 
BMI is a measure by an individual’s weight in kilograms divided by the height in 
meters squared. Though BMI does not directly measure body fat, a high BMI score is an 
indicator of body fatness.  
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Smoking  
Smoking was assessed by participants’ response to the question “have you 
smoked at least 100 cigarettes in life. Responses were coded into a binary variables in 
which participants either received a “1” when answering “yes” or a “0” when answering 
“no”.   
Data Analysis 
LPA is also a person-centered approach that accounts for intra-individual 
variation in different biomarkers use to better represent multiple biological pattern of 
biological risk (Marsh, Lüdtke, Trautwein, & Morin, 2009). Using this analysis approach 
to determine biological risk groups as an outcome variable is novel and somewhat 
exploratory. Therefore, final determination of the outcome variable (biological risk 
profile) can only be obtained after the completion of AIM 1. Each hypothesis and 
directionality between predictor and outcome variables have been derived from the 
weathering hypothesis, preliminary cluster analysis, and cardiovascular epidemiological 
data. Note that preliminary work indicated that we may identify groups of individuals 
who fall into low risk profiles such as profile number four seen in Figure 1.   I anticipate 
that a similar profile will emerge in the data and this profile will serve as the referent 
group for our analyses. 
Latent profile analysis (LPA) offers a probability based clustering or classification 
that allows for probability testing. Latent profile analysis draws on the assumption that a 
population, in which the sample is derived, follows a statistical model of probability 
(Vermunt & Madigson, 2002).     Under this assumption, classification of individuals 
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based on their observed scores should follow the same probability distribution. In the 
context of my research interest, a latent profile class that determines a cardiovascular risk 
profile is assumed to follow the same probability of that of the population in which it was 
derived. The use of a probability distribution, allows one to test a hypothesis on class 
membership against a p-value.    A latent profile model represents the distribution of 
biomarkers and other indicator variables as a function of probability of latent class 
membership.  A latent profile model, as a function of probability, also allows for 
maximum likelihood estimation which provides estimated probabilities of class 
membership.  Therefore selected fit criteria can be utilized to determine the latent profile 
model that best represents the estimated probability distributions for each latent profile 
class (Nylund, Asparouhov, & Muthén, 2007; Vermunt & Magidson, 2002).  
LPA will be utilized to develop risk profiles. Selected biomarkers will be log 
transformed so that standardized Z-scores for each biomarker will be used in the latent 
profile model.   LPA, conceptually similar to cluster analysis, will be used to assign 
individuals to mutually exclusive subgroups based on distinct patterns of z-scores for 
each biomarkers (Muthen, 2006). Using Mplus version 7 several LPA models will be 
conducted to determine the best model fit. Beginning with a one class model, the number 
of classes will be increased until fit indices suggest the most accurate model.  The 
following fit indices will be considered: Bayesian Information Criterion (BIC), Akaike 
Information Criterion (AIC), and the Lo Mendel Rubin (LMR) which provides a p-value 
in which a value less .05 suggests the model with one less class should be rejected in 
support of the model in question.  Using full information maximum likelihood (FIML) 
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estimation, LPA will allow for missing data in the development of risk profiles. After the 
risk profile groups are identified, multinomial logistic regression modeling will be used 
to determine the role of age and sex on membership in biological risk profile. The output 
from this analysis will provide profile membership which will be the primary dependent 
variable for the following analyses. This is similar to running a Confirmatory Factor 
Analysis as the first step in a Structural Equation Model.  It is a crucial step because it 
sets the stage for all further analyses which will employ multinomial logistic regression 
to examine predictors of profile membership.  
Multinomial logistic regression has been used to determine the probability of a 
dependent variables membership in category membership as a result of multiple 
independent variables.   The probability of categorical membership is evaluated by use of 
maximum likelihood estimation.  Multinomial regression is an ideal analysis as it does 
not require consideration of sample size and identification of outliers.   Further, 
multinomial logistic regression analysis is not influenced by issues of normality, 
linearity, or homoscedasticity.     
Multinomial logistic regression assumes several assumptions. Multinomial 
regression assumes that the membership in one category is not related to the membership 
in another variable. In addition, multinomial regression assumes non-separation.   
Therefore, predictors with perfect separation will result in inaccurate coefficients that are 
greatly overestimated.    
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Multinomial logistic regression modeling will be used to test the relationship 
between depression, social support and risk profile membership.   Several logistic models 
will be created to examine these relationships while understanding the moderating role 
off social support and cardiovascular risk.   
Study Limitations 
Though this study is novel in approach, there are several limitations. First, the 
study approach consists of a cross-sectional design. One aspect of the weathering 
hypothesis hinges on physiological deterioration over time. Though we examine age as a 
major variable, the study can be strengthened by the use of longitudinal study design. 
Though this goes beyond the scope of this dissertation study, future studies could employ 
longitudinal study methods to account for allostatic load over time.  Future studies should 
seek to examine this relationship.    Further, NHANES is a rich national dataset that 
allows for examination of racial differences in biological risk across the lifespan.  
However, this data set did not include measures of primary mediators (e.g., cortisol, 
norepinephrine, epinephrine). Though examining secondary mediators of stress is 
informative, investigation of primary mediators of stress is important for linking 
biological risk due to stress to clinical outcomes.  Future research should consider using 
primary mediators of stress to further validate and strengthen the biological risk patterns 
found in this study.
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CHAPTER IV 
 
CARDIOVASCULAR RISK PROFILE MEMBERSHIP IN THE NATIONAL 
HEALTH AND NUTRITIONAL EXAMINATION SURVEY: A LATENT 
PROFILE ANALYSIS 
 
 
Additional Authors: Dudley, William, PhD, Morrison, Sharon, PhD, Schulz, 
Mark, PhD, Wideman, Laurie, PhD 
 
 
Introduction 
 
Although rates of morbidity and mortality from cardiovascular disease have 
improved over the past decades, racial disparities in cardiovascular disease risk have 
persisted for ethnic and racial minorities (Berry et al., 2012; Go et al., 2014; Romero, 
Romero, Shlay, Ogden, & Dabelea, 2012).  Research seeking to explain these disparities 
has largely focused on  traditional risk factors such as obesity, hypertension, diet, and 
physical activity (Daviglus, Pirzada, & Talavera, 2014; Mathieu et al., 2012; Romero et 
al., 2012). However, a large body of literature has evidenced the psychological and social 
implications of race on cardiovascular risk (Jackson, McGibbon, & Waldron, 2013; 
Krieger et al., 2013; Sims et al., 2012).  The weathering hypothesis, posits that stress 
associated with racial inequities may cause health deterioration among African 
Americans as early as young adulthood, leading to racial disparities in health outcomes 
over the life span.  Further, African Americans often report stress associated with
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perceived racism and discrimination.  African Americans can experience racism and 
discrimination on multiple levels, including interpersonal (discriminatory interactions 
between individuals), institutional (discrimination in employment, housing, or health 
care), and cultural (widespread acceptance of stereotypes) (Harrell, 2000; Jones, 2000; 
Krieger, 1999).  Racism and discrimination also increases the likelihood of objective 
stressors such as job insecurity and financial strain (Arrow, 1998; Pager & Shepherd, 
2008) Stress associated with  economic, social, and structural inequities accelerates 
physiological erosion or “weathering” particularly among African American women 
(Geronimus, 2000; Geronimus & Thompson, 2004). Weathering is believed to create age 
patterns of morbidity and mortality among younger African Americans that are similar to 
older Whites thus creating differences in racial and age patterns in health outcomes of 
cardiovascular disease, infant mortality, death, and disability (Geronimus, 1996; 
Geronimus, Hicken, Keene, & Bound, 2006; Warren-Findlow, 2006; Geronimus et al., 
2010). 
Allostatic load is widely accepted as a quantitative metric used to study the 
consequences of weathering, thus giving researchers the ability to measure both the acute 
and long-term outcomes of the stress response. These efforts have been driven by 
literature linking social factors such as neighborhood quality, poverty, and occupation to 
physiological measures such as cortisol, blood pressure and levels of glycohemoglobin 
(Seeman, Singer, Wilkinson, & McEwen, 2001; Schnorpfeil et al., 2003; Barrington et 
al., 2014).  Allostasis is the process that activates the sympathetic nervous system, 
hypothalamic-pituitary-adrenal axis (HPA) and the immune systems to adapt to external 
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stressors. Prolonged allostasis results in allostatic load, a state of impaired ability to adapt 
to future stressors (Seplaki et al., 2004). The measurement of allostatic load is based on a 
set of biomarkers which represent the current state of each physiological system activated 
during stress exposure.  Previous studies have employed an algorithm that includes 
measures of the hypothalamic-pituitary-adrenal (HPA) axis (e.g., cortisol), cardiovascular 
system (e.g., blood pressure), metabolic processes (e.g., glycohemoglobin) and the 
immune system (e.g. C-reactive protein)(Seeman et al., 1997; Geronimus et al., 2006; 
Chyu & Upchurch, 2011; Brody et al., 2013). This algorithm computes  allostatic load  by 
demarcating clinical cut points to dichotomize continuous biological measurement into 
binary high risk variables (0 = low, 1 = high).   These binary variables (one for each 
biomarker) are then summed to yield an allostatic load score which determines the 
presence of allostatic load.  Higher allostatic load in general have been associated with a 
decline in physical and cognitive functioning, cardiovascular disease incidence, and 
mortality (McEwen & Seeman, 1999). Moreover, evidence suggests that African 
Americans have a greater probability than Whites of a high allostatic load with racial 
differences growing more pronounced with increasing age (Geronimus et al., 2006). 
Although this method of examining physiological weathering has been 
foundational (Seeman et al., 1997; Geronimus et al., 2006), there are three important 
limitations to this approach.  First, clinical cut points may not capture the full extent of 
biological risk (Royston, Altman, & Sauerbrei, 2006). For example, low values for 
albumin in the presence of other elevated biomarkers has shown specific clinical 
significance (Kuller et al., 1991; Lee et al., 2010). Secondly, categorizing otherwise 
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continuous data results in loss of valuable information captured by the variables used to 
calculate allostatic load (Altman, Lausen, Sauerbrei, & Schumacher, 1994; J. Cohen, 
1983).  This could be problematic when determining risk stratification for those who are 
near but do not meet the clinical thresholds of risk. Third, it is improbable that each 
biomarker equally contributes to the calculation of an allostatic load score. A 
dichotomized composite score presents challenges when determining the extent in which 
a specific biomarker drives an allostatic load score. Further, cases may exhibit high 
allostatic load scores but exhibit different patterns of elevated biomarkers.  For instance, 
an individual may exhibit elevated C-reactive protein, triglycerides, cholesterol and 
homocysteine while another individual may exhibit elevated of homocysteine, albumin, 
and creatinine and C-reactive protein.  Therefore, dichotomizing allostatic load scores 
may mask the physiological nature of allostatic load.   
This standard practice of computing allostatic load has supported fundamental 
research of the nature of racial/ethnic disparities in chronic diseases. We propose an 
alternative approach, which is believed to improve data sensitivity and reduce 
information loss. Therefore the purpose of this study was to expand upon the weathering 
hypothesis by addressing the limitations of utilizing a traditional algorithm for computing 
allostatic load.  In this process we conducted a latent profile analysis (Masyn, 2013; B. 
Muthén, 2006) using continuous level biomarkers commonly used to assess allostatic 
load. In addition to addressing the limitations of the traditional methodology, we 
broadened the scope of the study to include a sample of Hispanics.  Evidence of 
weathering has been consistent for African Americans but mixed among studies 
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examining weathering among Hispanic populations (Collins, Rankin, & Hedstrom, 2012; 
Wildsmith, 2002). Therefore our study sought to examine racial differences in 
memberships in cardiovascular risk profile among Whites, African Americans, and 
Hispanics. We also examined age and sex differences in risk profiles memberships.  
Methods 
Participants and Measures 
We utilized data from the 2005-2006 National Health and Nutritional 
Examination Survey (NHANES) collected by the National Center for Health Statistics. 
NHANES collects national data from both interviews and examinations. The interview 
portion collects data on demographics, socioeconomic status, diet, and health outcomes 
while the examination portion collects medical, dental, physiological measurements, and 
laboratory data.   NHANES employs a stratified multistage probability sample that 
represents the United States population for civilian, noninstitutionalized individuals. 
Thus, in addition to the breadth of data collected, a national probability sample was also a 
major advantage to this study.  
Respondents who self-identified as Mexican, Other Hispanic, Non-Hispanic 
Black, Non-Hispanic White, and other race including Multi-Racial were recruited for 
participation in NHANES. Oversampling of individuals aged 60 and older, Blacks, and 
Hispanics allowed for an increase in the reliability of statistical analysis. NHANES 
provided a weighting variable to compensate for oversampling.  
 
 
 
52 
 
Procedure  
Given that this study was designed to provide an alternative approach to the 
traditional allostatic load algorithm, we conducted a latent profile analysis to develop 
cardiovascular disease risk profiles. On the premise of existing research examining 
biomarkers of stress and the data availability, 7 biomarkers were selected for inclusion in 
a latent profile analysis; C-reactive protein, total cholesterol, glycohemoglobin, 
homocysteine albumin, creatinine clearance, and triglycerides were collected via 
participant blood samples.  Latent profile analysis (LPA) was used to develop risk profile 
categories. LPA is conceptually similar to cluster analysis as this analysis assigns 
individuals to mutually exclusive subgroups (classes) based on a set of “indicator” 
variables.(Masyn, 2013; B. Muthén, 2006)  LPA is a special case of Latent Class 
Analysis (LCA) in which the indicators are continuous as opposed to categorical.  Unlike 
LCA, LPA does not assume local independence which limits the possibility of covariance 
among indicator variables used in latent profile models.   Thus, use of LPA allows for 
flexibility in the structure of the classes in regards to the means, variances and 
covariances of the indicator variables.  The default in LPA is that the means of the 
indicator variables are free to vary across classes (thus resulting in different profiles 
across classes).   In addition, one may allow the variances and covariances of the 
indicator variables to be either invariant or unrestricted across classes.  The specification 
of the means structure can have a significant impact on the number and characteristics of 
classes.  
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Statistical Approach 
A conservative approach was adopted in the development of the model class 
structure. First, each biomarker was transformed into standardized Z-scores based on raw 
data to account for different units of measurements among each biomarker.  Many of the 
biomarkers exhibited a highly positive skew. To our knowledge, there are no strong 
recommendations regarding the impact of skewness on latent profile analysis.  Therefore 
we adopted a systematic approach for trimming the raw data.  We established three levels 
of trimming at the 99th percentile, 97th percentile and the 95th percentile.  Using the raw 
data and the three levels of trimming we estimated a series of LPA models ranging from 
2 – 7 classes. Models with untrimmed data often did not converge thus creating rationale 
for utilizing trimmed data. We also allowed variable correlation within classes during 
model development.  Identification of an ideal number of classes was determined through 
a series of steps.    
First, we adopted the assumption that the pattern of means held unrestricted 
variance across classes (this is the default assumption in LPA).  Second, because the 
formula for computing total cholesterol incorporates some portion of the triglycerides 
value, we allowed total cholesterol and triglycerides to covary across all classes with the 
restriction that this covariance was invariant across classes.  Third, we allowed the 
variances and the pattern of variance among the indicator variables to vary across classes.   
Using Mplus version 7, (Muthén & Muthén, 2012) changes across the number of 
classes were examined in respect to the following fit indices; Akaike Information 
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Criterion (AIC), Bayesian Information Criterion (BIC), and the Sample Size Adjusted 
Bayesian Information Criterion (SS-BIC).  Secondly, we employed the Lo-Mendell-
Rubin (LMR) test to determine the appropriateness of K versus K+1 number class. We 
were unable to employ the bootstrapped LMR as NHANES utilizes sample weights.  
Lastly, we examined the distribution of cases across each class to identify symmetry 
within the latent profile model. (Masyn, 2013)     
Multinomial logistic regression analysis was used to determine odds of risk 
profile membership for race (African American, White, Hispanic), sex, age and family 
income to poverty ratio.  Age for this study ranged from 3-85 years. The family income 
poverty ratio is calculated by dividing family income, specific to family size, by the 
poverty guidelines set forth by the Department of Health and Human Services (HHS).  
These guidelines are used to determine eligibility for federal assistance programs such as 
the Supplemental Nutrition Assistance Program (SNAP), Special Supplemental Nutrition 
Program for Women, Infants, and Children (WIC), and the National School Lunch 
Program. Sampling weights as provided by NHANES were also employed.  
Results 
Latent Profile Model 
 
A series of models were run on each of level of trimming which revealed that 
trimming at the 97th percentile resulted in the best fit.  This level of trimming resulted in a 
total sample size of 7436.  LPA revealed a 4-class solution. See Table 1.  
 
 
 
55 
 
Table 1. Fit Indices for 4 Profile Solution. 
 
 
 
 
Figure 3.  Cardiovascular Risk Profiles for 4 Profile Solution. 
 
 
 
The standardized means for each biomarker including in the 4 profiles are 
depicted in Figure 2. These means and the results of the one way analysis of variance 
(ANOVA) for each profile are presented in Table 2.  The one-way analysis of variance 
produced an F statistics that indicated the presence of significant variation among each 
biomarker across the profiles.  The first profile revealed the youngest participants with a 
mean age of 20 years (n= 2206, 29.6%). This profile revealed patterns of increased levels 
of Albumin while exhibiting lower levels of C-reactive protein, glycohemoglobin, 
triglyceride, homocysteine and cholesterol levels.  Minimal variation was observed for 
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creatinine levels among members of this profile. On the basis of scientific literature, this 
profile was classified as the low risk profile (Mueller & Caudill, 1999).  The second 
profile yielded a mean age of 46.   This profile held the largest number of participants 
(n=2,473, 33.2%) and revealed elevated levels albumin, creatinine, and cholesterol.  
Elevated levels of both albumin and creatinine indicate some degree of kidney 
risk(Peralta et al., 2011), thus we categorized this profile as a kidney risk profile.   The 
third profile (n=12211, 16.5%) revealed elevated levels of C-reactive protein but 
exhibited low levels of albumin, creatinine, glycosylated hemoglobin, and homocysteine. 
Triglycerides and total cholesterol demonstrated minimal to no variation within this 
profile.  The mean age for this profile was 33 years.  Research indicates that low albumin 
levels in the presence of elevated C-reactive protein may represent an inflammatory risk, 
particularly among those with chronic disease (Menon et al., 2005). Therefore, we 
labeled this profile inflammatory risk. The fourth profile (n= 1146, 20.7%) yielded the 
highest overall risk as this profile was characterized by increased levels of creatinine, 
glycohemoglobin, and homocysteine with moderate levels of C-reactive protein.   Based 
on the clinical literature, this profile was classified as an overall vascular risk profile 
(Hackam & Anand, 2003).  The mean age for the vascular risk profile was 61 years.   
 
 
 
      Table 2.  Mean Scores and ANOVA for Risk Profiles 
 Low Profile 
  
N= 2,200 (29.6%) 
  
Mean Age = 20 
Kidney Profile 
  
N= 2,473 (33.2%) 
  
Mean Age= 46  
Vascular Profile 
  
N= 1,221 (16.5%) 
  
Mean Age= 61    
Inflammatory Profile 
  
N= 1,541 (20.7%) 
  
Mean Age = 33 
  
   
   
      
Variables 
Mean Z-
Score SD 
Mean Z-
Score SD 
Mean Z-
Score SD 
Mean Z-
Score SD F 
Albumin 0.51 0.69 0.37 0.63 -0.38 0.81 -0.72 1.19 730.69**  
C-reactive 
Protein 
-0.41 0.04 -0.26 0.13 0.26 0.54 0.24 0.52 1954.37** 
 
Creatinine -0.24 0.41 0.20 0.42 0.38 0.63 -0.46 0.34 1009.23**  
Glycohemoglobin -0.39 0.34 -0.12 0.39 0.35 0.63 -0.30 0.43 668.34**  
Triglyceride -0.39 0.31 0.05 0.66 0.06 0.63 -0.06 0.61 382.33**  
Homocysteine -0.36 0.37 -0.02 0.39 0.40 0.60 -0.60 0.32 984.25**  
Cholesterol -0.56 0.66 0.19 0.80 0.01 0.83 -0.03 0.84 280.61**  
5
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Multinomial Regression 
We conducted a multinomial logistic regression using the low risk profile as the 
referent group.    This analyses were designed to determine which predictive variables 
(age, race, and poverty income ratio) were related to profile membership in the 3 focal 
profiles compared to low risk profile.  All of the predictive variables were entered 
simultaneously into each model.   Table 3 displays the results of our multinomial 
regression with the low risk profile as the referent group. Negative coefficients were 
indicative of greater odds of membership in the reference profile while a positive 
coefficient indicated greater odds of membership in the focal profile.   
Compared to Whites, Hispanics had a significantly greater odds of membership in 
the inflammatory risk profile only (OR= 1.94) while African American participants held 
significant greater odds of membership in both the inflammatory risk profile (OR= 4.29) 
and the vascular risk profile (OR= 1.35). Age was also found to be a significant predictor 
risk profile membership. Compared to low risk profile, older participants have greatest 
odds of membership in the vascular risk profile (OR= 1.23). This was followed by odds 
of membership in the kidney risk (OR= 1.23) and inflammatory risk profiles (OR= 1.6).  
Females were significantly less likely to be in the kidney risk profiles and vascular risk 
profiles but much more significantly likely to be in the inflammatory risk profile (OR= 
4.11).  Poverty to income ratio (PIR) was also a significant predictor of risk profile 
membership. Those with higher PIR scores were the least likely to be in the 
Inflammatory Risk Profile (OR= .19).  Higher PIR scores were also less likely to be in 
the hypertension risk (OR = .88) and Vascular Risk (OR= .71).  
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Table 3.  Results of Multinomial 
Regression for 4 Profiles. 
    
Kidney Risk Profile Logit SE OR p-value 
Hispanic -0.14 0.199 0.87 0.483 
African American 0.238 0.216 1.27 0.27 
Age 0.147 0.014 1.16 0.001* 
Female -2.966 0.367 0.05 0.001* 
PIR -0.128 0.054 0.88 0.017* 
Vascular Risk Profile          
Hispanic -0.216 0.267 0.81 0.418 
African American 1.456 0.245 4.29 ˂.001* 
Age 0.205 0.015 1.23 ˂.001* 
Female -2.904 0.384 0.05 ˂.001* 
PIR -0.34 0.063 0.71 ˂.001* 
Inflammatory Risk Profile         
Hispanic 0.665 0.131 1.94 ˂.001* 
African American 0.301 0.13 1.35 .021* 
Age 0.054 0.007 1.06 ˂.001* 
Female 1.413 0.215 4.11 ˂.001* 
PIR -1.65 0.038 0.19 ˂.001* 
SE=Standard Error     
OR= Odds Ratio     
PIR Poverty Income Ratio     
*Indicates Significance     
White & Male used for reference for race and gender predictor variables 
Protective Profile use for reference profile   
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Discussion 
Using a cross-sectional design, we aimed to advance the weathering hypothesis by 
investigating potential pathways that may present various patterns of cardiovascular 
disease risk stratification among a national sample. Using continuous level variables 
rather than dichotomized variables revealed different patterns of biomarkers. This 
suggests there may be different stratifications of cardiovascular disease risk contributing 
to overall allostatic load. The LPA yielded three distinct patterns of risk (kidney, 
vascular, and inflammatory) with one profile identified as a low risk profile. Members of 
the low risk profile exhibited increased levels of albumin and lower levels of all other 
biomarkers. Previous research conducted with NHANES found a higher prevalence of 
albumin excretion in children than adults (Mueller & Caudill, 1999).  The average age in 
the low risk profile was 20 years, representing a large number of participants under 18 
years old.  Evidence suggests that elevated levels of albumin are a normal part of 
development in children (Bangstad, Dahl-Jørgensen, Kjaexsgaard, Mevold, & Hanssen, 
1993). However, there is a need to investigate the role of elevated albumin in the 
susceptibility to chronic diseases over the lifespan.     
We also observed the starkest racial disparities among members of the overall 
vascular risk profile.  Compared to Whites, African Americans were about four times 
more likely to be members in the vascular risk profile versus the low risk profile. This 
risk was heightened if participants were male.  The overall vascular risk profile exhibited 
the most likely risk of cardiovascular disease. Particularly, the combined effects of C-
reactive protein and glycohemoglobin has been associated with the progression of 
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advanced early atherosclerosis and increases the risk of a vascular event for both 
diabetics and non-diabetics (Sander et al., 2006).  Further, the presence of homocysteine, 
which is believed to irritate the lining of the blood vessel, has been associated with heart 
disease, stroke, and increased the overall risk of cardiovascular disease (Wald et al., 
2002).  We also observed that lower PIR predicted risk for all risk profiles. . However, 
the lowest PIR was associated with overall vascular risk.   
Consistent with weathering hypothesis, these findings provide evidence that age 
alone does not contribute to overall cardiovascular risk. The impact of chronic stress from 
limited financial resources may contribute to increasing cardiovascular risk among 
African Americans. Further, the weathering hypothesis juxtaposes that living in a race-
conscious society contributes to both limited access to financial resources and exposure 
to subjective racial stress leading to early health deterioration of health than Whites.  We 
found that African Americans and Hispanic were more likely to have an inflammatory 
risk.   Patterns of C-reactive protein and albumin in the inflammatory risk profile were 
similar to systematic inflammatory responses in chronic diseases such as cancers and 
cardiovascular diseases while increasing the likelihood of all-cause mortality (Kuller et 
al., 1991; Menon et al., 2005).  We found that Hispanic and African American 
participants held greater odds of membership of the inflammatory risk profile. Further, 
females were over four times more likely than males to be in this profile.  In our study, 
we found the mean age for the inflammatory risk profile was 33 years. Geronimus and 
colleagues (2006) found the largest racial differences in physiological breakdown among 
those between the ages of 35-64 with lower PIR.  This profile may portray the initial 
 
62 
 
biological patterning of physiological breakdown among minorities who are experiencing 
allostatic load.  This pattern may be more pronounced among females with lower 
socioeconomic statuses. 
The kidney risk profile yielded a different risk stratification that was evidenced by 
increases in albumin, creatinine, and cholesterol. Elevation of these biomarkers has 
predicted hypertension, atherosclerosis, and renal injury (Lee et al., 2010). The presence 
of kidney disease has been a strong predictor of cardiovascular disease (Strippoli et al., 
2008).    There is a high prevalence of kidney disease among African Americans, 
particularly among those 65 years and up. Therefore, we expected to find that African 
Americans had the greatest odd of membership in the kidney risk profile.  However, we 
did not observe any significant racial differences in membership in the kidney risk profile 
versus the low risk profile for Hispanics. We did find that membership in the profile was 
significantly predicted by increase in age, lower PIR, and being male. We speculate that 
there may be limited racial differences in kidney risk between the ages of 40-50.   
However, racial differences may be revealed as age increases, particularly among those 
with limited financial resources.  Also consistent with literature, this increase kidney risk 
may be exacerbated for African American males (Jacobs et al., 2002). 
 We have identified different cardiovascular risk stratifications by age, race, and 
sex demonstrating that the physiological stress response may differ across specific 
populations.   Future investigative efforts should examine the relationship between 
psychosocial stressors (e.g. racism, discrimination, life stress) and various patterns of 
cardiovascular risk.  A large body of research examining the weathering hypothesis finds 
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that minority women, particularly African American women hold the highest biological 
risk.  However, we found that males were more likely to exhibit kidney and overall 
vascular risk, indicating the physiological drivers of allostatic load may differ by sex.  
Our findings also provide several opportunities to enhance treatment options and 
tailored preventative interventions across the lifespan.  For example, clinical 
interventions may consist of screening for inflammatory biomarkers for African 
American and Hispanic women beginning at the age of 30.  This may be useful in 
identifying women who have sub-clinical cardiovascular risk.    Moreover, enhancing 
cultural and age specific coping efforts with other resources such as social support may 
be important in reducing biological risk for African American and Hispanic women who 
exhibit similar inflammatory biomarker patterns.  The biological pattern exhibited in the 
kidney risk profile may also indicate early cardiovascular risk via kidney susceptibility 
before racial disparities are revealed. This provides the opportunity to examine 
psychosocial factors that contribute to increasing racial disparities among participants 
who exhibit kidney susceptibility, particularly those who are over 40 years old.   
The present study held several limitations. Assignment of latent profile groups is 
probabilistic in nature and does not yield conclusive subgroups in the population. Profile 
grouping is determined by the indicator variables included in the latent profile model.  
Further, NHANES is a rich national dataset that allows for examination of racial 
differences in biological risk across the lifespan.  However, this data set did not include 
measures of primary mediators (e.g., cortisol, norepinephrine, epinephrine). Though 
examining secondary mediators of stress is informative, investigation of primary 
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mediators of stress is important for linking biological risk due to stress to clinical 
outcomes. Future research should consider using primary mediators of stress to further 
validate and strengthen the biological risk patterns found in this study. Moreover, we 
included acute phase biomarkers, such as C-reactive protein in this study.  Acute phase 
biomarkers may not be completely indicative of the cumulative physiological burden of 
the stress. Though this study accounted for outliers for each biomarker, this study cannot 
fully determine the degree in which the results are influenced by current physiological 
states, such as the presence of an active infection.   
 
65 
 
CHAPTER V 
 
THE ASSOCIATIONS BETWEEN DEPRESSION, SOCIAL SUPPORT AND 
CARDIOVASCULAR RISK PROFILE MEMBERSHIP 
 
 
Additional Authors: Dudley, William, PhD, Morrison, Sharon, PhD, Schulz, 
Mark, PhD, Wideman, Laurie, PhD 
 
 
Introduction 
Depression and cardiovascular disease are two of the most common causes of 
disability across the world (Murray & Lopez, 2013).    Evidence suggests there is a 
complex and bidirectional relationship between cardiovascular disease and depression  
(Lippi et al., 2009).  There is evidence that cardiovascular disease contributes to the onset 
of depressive symptoms.   One out of every five patients with cardiovascular disease will 
report a major depressive disorder (Thombs et al., 2006).  Moreover, depression has also 
been shown to worsen cardiovascular disease prognosis and increase overall mortality 
from cardiovascular disease  (Barth et al., 2004; Ferketich et al., 2000; Frasure-Smith et 
al., 2000, 2000; Lett et al., 2004; Van Melle et al., 2004). Thus, the nature of the 
relationship between depression and cardiovascular disease is unclear and the mechanism 
or mechanisms for the complex interplay between depression and cardiovascular diseases 
remain unexplained.  
A growing body of literature provides evidence that depression increases the risk 
of cardiovascular disease. Researchers have found that an increase a depressive 
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symptomology predicts incidence of coronary artery disease, coronary heart disease, and 
myocardial infarction (Barefoot & Schroll, 1996; Charlson et al., 2011; Ferketich et al., 
2000; Keyes, 2004; Van der Kooy et al., 2007). Psychosocial factors have been shown to 
increase the risk of cardiovascular disease more so than traditional risk factors (e.g. 
hypertension, diet, exercise) (Joynt et al., 2003; Kim & Setias, 2016; Lett et al., 2004).  A 
study conducted by Yusuf and colleagues (2004) found that psychosocial factors such as 
perceived stress, negative life events, and depression were stronger risk factors for 
cardiovascular disease than diabetes, smoking, hypertension, and obesity (Yusuf et al., 
2004). Further, a positive relationship has been observed between the severity of 
depressive symptomology and risk of cardiovascular disease (Barefoot & Schroll, 1996; 
Charlson et al., 2011).  On the premise of this study and other studies examining the 
global burden of cardiovascular disease, the 2010 Global Burden of Disease study 
recognized depression as a recognized risk factor for coronary heart disease (Charlson et 
al., 2011).   There also may be a positive interaction between depression and traditional 
CVD risk factors as existing literature finds that traditional cardiovascular risk factors 
may strengthen the association between depression and cardiovascular disease risk 
(Rugulies, 2002).   
  National data suggests that rates of depression diagnosis are increasing across all 
races and ethnicities. A study examining data from the National Ambulatory Medical 
Care Survey from 1992-1993 to 2003-2004 found that depression diagnoses rose from 
4.8 to 7.0 per 100 for Hispanics, 4.2 to 7.6 for African Americans and 10.9 to 15.4 for 
whites (Sclar et al., 2008). Although Whites exhibit higher depression diagnosis, the 
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burden of depression is higher among minorities.  In a national epidemiological study of 
mental health and service usage, 63.7% of Latinos and 58.8% of African Americans 
lacked access to mental health treatment compared to 40.2% of Whites (Alegría et al., 
2015; Williams et al., 2007). Further, African Americans have been shown to have the 
highest rate of severe depressive symptoms over the longest length of time (Pratt & 
Brody, 2014; Williams et al., 2007). These findings suggests minorities often have an 
increased burden of severe depressive symptoms disability even though Whites have a 
higher prevalence of depression.   
Disparities in depression diagnoses are apparent early in the lifespan as evidence 
suggests that racial/ethnic minority adolescents have higher rates of depressive symptoms 
and limited access to treatment (Alexandre et al., 2009; Cummings & Druss, 2011). For 
example,  In a study comparing White and Hispanic youth, Whites (36%) were 
significantly more likely than Hispanics (27%) to receive adequate mental health 
(Alexandre et al., 2009). Further, Cummings and colleagues used data from the National 
Survey on Drug Use and Health to examine racial/ethnic differences in mental health 
services for White, African American, Hispanic, and Asian adolescents. Results of the 
study showed that when accounting for family income and insurance status, African 
American, Hispanic, and Asian adolescents were significantly less likely than Whites to 
receive prescription medication for depression, receive treatment from a health care 
provider, or receive outpatient mental health treatment (Cummings & Druss, 2011).  
Depression has been shown to alter a number of biological mechanisms, including 
autonomic nervous system function, HPA axis function, inflammation and insulin 
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resistance (Joynt et al., 2003; Kiecolt-Glaser & Glaser, 2002; Lett et al., 2004; B. S. 
McEwen, 2003; Miller et al., 2002; Taylor, 2010; Thayer et al., 2010; Vrany et al., 2015).  
Depression, particularly chronic depression represents a persistent stress state which may 
erode the physiological stress response systems (Juster et al., 2011; Kobrosly et al., 2014; 
McEwen, 1998;  McEwen, 2003). Depression is believed to activate the allostatic 
processes that adapt to external stress. Allostasis activates the sympathetic nervous, 
hypothalamic-pituitary-adrenal axis (HPA) and the immune systems in response to 
external stress. Moreover, chronic activation of allostasis leads to biological wear and 
tear or “weathering”, increasing the probability of allostatic load.  In an allostatic load 
state, the physiological stress response becomes impaired, reducing the ability to 
functionally adapt to future stressors (Seplaki et al., 2004). Allostatic load has been 
associated with a decline in physical and cognitive functioning, cardiovascular disease 
incidence, and mortality (Geronimus et al., 2006; McEwen & Seeman, 1999; Seeman et 
al., 1997).  
The weathering hypothesis may explain how disproportional rates of depression 
among minorities account for some cardiovascular disease disparities. This hypothesis 
proposes that chronic stress over the lifespan accelerates biological weathering among 
minorities (Geronimus, 2000; Geronimus & Thompson, 2004).     Evidence suggests that 
minorities are prone to economic and social stressors that increase the likelihood of 
depressive symptomology (Mezuk, Rafferty, et al., 2010).  Further, minorities often 
report exposure to racism and discrimination, which can contribute to depressive 
symptomology (Banks & Kohn-Wood, 2007; Flores et al., 2008).  Sellers and colleagues 
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(2006) found the racial discrimination reduced psychological well-being, while 
increasing depressive symptoms, and perceived stress (Sellers et al., 2006).  Further, 
racism has been shown to facilitate depressive symptoms by threatening self-esteem, 
invoking sense of hopelessness, and normalizing failure (Clark et al., 1999).  
The presence of social support has been shown to decrease cardiovascular disease 
risk and mortality (Berkman et al., 1992; S. Cohen & Wills, 1985; Frasure-Smith et al., 
2000; Treiber et al., 2003).  Two main hypothesis that have sought to explain this 
relationship. First, it is hypothesized that social support may exhibit independent effects 
on cardiovascular risk (House et al., 1988). For example, social support may decrease 
cardiovascular risk by facilitating healthy behaviors such as exercise, healthy eating, and 
adherence to medical treatment (DiMatteo, 2004; Franks et al., 1992; Lewis & Rook, 
1999; Uebelacker et al., 2013)   Secondly, social support may buffer the relationship 
between of depression and cardiovascular risk (Cohen & Wills, 1985; George et al., 
1989). Higher family support has also been shown to lower the association between 
depression symptoms and stressors such as racial discrimination (Brody et al., 2006; Noh 
& Kaspar, 2003; Uebelacker et al., 2013; Wei et al., 2010).    Moreover, the absence of 
support has been associated with the onset of depression both independently and through 
modifying perceptions of negative life events (Paykel, 1994).  
Thus, the purpose of the study was to examine the mechanisms in which 
depression may increase the risk of cardiovascular disease. Further, we sought to 
understand whether previous literature suggesting that social support reduces 
cardiovascular disease risk holds true in a study that examines the relationship between 
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depression and cardiovascular disease risk. This study, guided by the weathering 
hypothesis, assumes that depression contributes to the development of allostatic load. 
Traditionally, allostatic load is determined by an algorithm that demarcates clinical cut 
points to dichotomize continuous biological measurement into binary high risk variables 
(0 = low, 1 = high). Biomarkers included in these calculation represent the state of the 
physiological systems activated in the stress response (e.g., C-reactive protein, 
glycohemoglobin, albumin). This value is then summed to yield an allostatic load score 
which determines the presence of allostatic load. Previous work conducted by Johnson et. 
al., suggests that cardiovascular risk is variant across race/ethnicity, age and 
socioeconomic statuses.  Johnson and colleagues examined allostatic load biomarkers 
used to assess allostatic load and found that 4 distinct cardiovascular risk profiles; low 
risk profile, kidney risk profile, inflammatory risk profile, and vascular risk profile.  
Therefore, we sought to extend this method of examining cardiovascular risk by 
incorporating the psychosocial variables depression and social support.  
Methods 
Participants  
The 2005-2006 National Health and Nutritional Examination Survey (NHANES) 
was used for the study analysis.  NHANES employs a stratified multistage probability 
sample of the United States population for civilian, non-institutionalized individuals.  
Participants who self-reported race ethnicity as Mexican, Other Hispanic, Non-Hispanic 
Black, Non-Hispanic White, other race including Multi-Racial were recruited for the 
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NHANES study. In our study, we focused on Hispanic (Mexican and Other Hispanic), 
African American, and White.  
Measures 
The PHQ-9 (α =0.89) is a 9 item depression scale that establishes criteria for 
depression diagnosis and rates the severity of depressive symptoms (Kroenke & Spitzer, 
2002).  This scale consist of 9 questions that measure the frequency of depressive 
symptoms (e.g.  little interest in doing things, feeling down depressed, or hopeless; 
difficulty these problems have caused) within the past 2 weeks.  Frequency was assessed 
on a scale of 0-3 with 0 indicating rarely experienced and 3 indicating a symptom was 
experienced most to all of the time. Higher mean PHQ-9 scores indicated a higher 
frequency and severity of symptoms.  The PHQ-9 is a shortened version of the primary 
care evaluation of mental disorders (PRIME-MD®) used for assisting health providers in 
determining criteria based diagnoses (e.g. mood, anxiety, alcoholism) commonly faced 
among medical patients (Spitzer et al., 1994).  The PHQ-9 is a self-administered three 
page version of the PRIME-MD® with a comparable sensitivity (65%-95%) and 
specificity (85%-95%) of lengthier depression scales (Kroencke et al., 2001).   
Emotional support, financial support, and social network were assessed using 
social support questions collected in NHANES. Emotional support was measured by 
participants’ response to the question, “Can you count on anyone to provide you with 
emotional support such as talking over problems or helping you make a difficult 
decision?” Financial support was measured by participants’ responses to, “If you need 
some extra help financially, could you count on anyone to help you; for example, by 
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paying any bills, housing costs, hospital visits, or providing you with food or clothes?”  
Emotional and financial support was coded into a binary variables in which participants 
either received a “1” when answering “yes” or a “0” when answering “no”.  Social 
network was measured by participants’ responses to the question “how many close friend 
do you have”. Close friends were defined as relatives or non-relatives that participants 
felt at ease with, could talk to about private matters, and who they believed they could 
call on for help. Participants’ responses could range from 0-50 friends.  
Statistical Analysis 
Seven biomarkers were selected for inclusion in a latent profile analysis; C-
reactive protein, total cholesterol, glycohemoglobin, homocysteine albumin, creatinine 
clearance, and triglycerides. These biomarkers were collected via participant blood 
samples. Risk profile categories were developed by latent profile analysis.   A 
conservative approach was adopted in the development of the model class structure. First, 
each biomarker was transformed into standardized Z-scores based on raw data to account 
for different units of measurements among each biomarker. Second, because many of the 
biomarkers exhibited a highly positive skew.  We followed trimming analysis similar to 
Johnson et. al. and trimmed at the 97th percentile. Using Mplus version 7(L. K. Muthén & 
Muthén, 2012), we estimated a series of latent profile models ranging from 2-4 classes 
changes and examined the following fit indices; Akaike Information Criterion (AIC), 
Bayesian Information Criterion (BIC), and the Sample Size Adjusted Bayesian 
Information Criterion (SS-BIC).  We also employed the Lo-Mendell-Rubin (LMR) test to 
determine the appropriateness of K versus K+1 number class. Although symmetry in 
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class size was not a requirement for our models, we were most interested in solutions 
with relative frequency. Thus, case distribution across each class was examined to 
identify symmetry within the latent profile model (Masyn, 2013).    
We used multinomial logistic regression analysis to determine odds of risk profile 
membership for race (African American, White, Hispanic), depression score and social 
support (emotional, financial, network).  Evidence suggests that social support may 
moderate the relationship between depression and cardiovascular risk.  Thus, interaction 
terms were created to examine whether moderation relationships might exist between 
depression and social support. We included the following covariates in the regression 
model; sex, age, family income to poverty ratio, BMI (kg/m**2), and smoking status 
(yes/no).  Age for this study ranged from 40-85 years. The family income poverty ratio is 
calculated by dividing family income, specific to family size, by the poverty guidelines 
set by Department of Health and Human Services (HHS). All of the predictive variables 
and covariates were entered simultaneously into each model.     
 Results 
Trimming analysis found that models with raw data did not converge and the 
trimming at the 97th percentile resulted in the best fitting model (see Johnson et. al. for 
procedure). This resulted in a sample size of 2,341.  LPA revealed a 2-class solution. The 
fit indices are reported in Table 4.  
The standardized means for each biomarker are including in Figure 3.  Table 5 
represents the standardize means and results of one-way analysis of variance for each 
profile. The one-way analysis of variance produced an F statistics indicating the presence 
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of significant variation across the profiles.  The first profile (n=1384, 59%) revealed a 
low risk profile similar to the profile found in work by Johnson and colleagues, thus we 
labeled this profile low risk.  This profile exhibited patterns of high levels of Albumin 
and lower levels of C-reactive protein, triglyceride, cholesterol levels, homocysteine and 
glycohemoglobin,.  The second profile (n= 957, 41%) revealed elevated levels of C-
reactive protein with slightly elevated levels of homocysteine. Low levels of Albumin, 
triglycerides, total cholesterol were observed in this profile while creatinine and 
glycohemoglobin yielded minimal to no variation.  Low albumin levels in the presence of 
elevated C-reactive protein has been characteristic an inflammatory risk (Menon et al., 
2005). Therefore, we labeled this profile inflammatory risk.  
 
 
  
 
 
 
 
 
 
 
 
 
Table 4. Fit Indices for 2 Cluster 
Solution 
   
 AIC BIC SSABIC LMR 
Class 2 23773.60 24142.12 23932.77 ˂.001* 
Class 3 22337.18 23290.64 22995.16 .76 
Class 4 21944.93 22647.41 22259.83 .78 
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Figure 4. Risk Profile Membership for Low Risk and Inflammatory Risk Profiles. 
 
 
Table 5.  Mean Scores and ANOVA for Risk Profiles 
 
Low Risk Profile 
 
Inflammatory Risk Profile 
 
 
  
  
          
Variables Mean Z-Score SD Mean Z-Score SD F 
Albumin 0.38 0.79 -0.36 1.00 395.55** 
C-reactive 
Protein 
-0.40 0.14 0.16 0.56 1109.48** 
Creatinine -0.15 0.34 -0.01 0.55 50.65** 
Glycohemoglobin -0.39 0.30 0.03 0.63 415.51** 
Triglyceride -0.19 0.60 -0.09 0.60 15.32** 
Homocysteine -0.25 0.39 0.06 0.65 195.60** 
Cholesterol 0.01 0.80 -0.19 0.90 30.05** 
 
 
We conducted a multinomial logistic regression using the low risk profile as the 
referent group.  Table 6 displays the profile descriptive for each profile group.  Table 7 
displays the results of our multinomial regression with the low risk profile as the referent 
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group. Negative coefficients were indicative of greater odds of membership in the low 
risk profile while a positive coefficient indicated greater odds of membership in the 
inflammatory risk profile We found that increasing depression score significantly 
increased the odds of membership in the inflammatory risk profile (OR= 1.36). We did 
not find a significant association between risk profile membership and social network, 
financial support, or emotional support. However, analysis revealed a moderating 
relationship between depression and emotional support. The association between 
depression and inflammatory risk profile membership was significantly reduced with an 
increase in emotional support (OR = .15). Compared to Whites, African Americans had a 
significantly greater odds of membership in the inflammatory risk profile (OR= 2.83).  
We did not find that evidence that being Hispanic predicted membership is a risk profile. 
Age was also found to be a significant predictor risk profile membership. We found that 
the mean age in the low risk profile (54 years) was slightly lower than that of the 
inflammatory risk profile (59 years). Subsequently, an increase in age significantly 
heightened the odds of inflammatory risk membership (OR= 1.6).  Poverty to income 
ratio was also a significant predictor of risk profile membership. Those with higher PIR 
scores were the less likely to be in the inflammatory Risk Profile (OR= .82).  Lastly, an 
increase in BMI increased the odds of membership in the inflammatory risk profile 
(OR=1.19). 
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Table 6. 2 Profile Descriptives 
 
 
 
 
 SE=Standard Error     
OR= Odds Ratio     
 PIR Poverty Income Ratio     
 *Indicates Significance     
 White & Male used for reference for race and gender predictor variables 
 Protective Profile use for reference profile   
   
 
 Low Risk Profile Inflammatory Risk  Profile 
Variables Mean SE Mean SE 
Age 54 .297 59 .419 
Depression Score .22 .009 .37 .016 
Social Network 7.38 .201 7 .28 
Financial Support 1.7 .011 1.76 .014 
Emotional Support 1.9 .006 1.94 .007 
BMI 26.99 .129 32.59 .258 
PIR 3.58 .040 2.83 .050 
Table 7.  Results of Multinomial Regression for 
Inflammatory Risk Profile. 
 
  
Inflammatory Risk Profile Logit SE OR p-value 
Hispanic 0.307 0.244 1.35 0.209 
Black 1.04 0.221 2.82 ˂.001* 
Age 0.05 0.009 1.05 ˂.001* 
Female 0.197 2.42 1.21 0.415 
BMI 0.178 0.023 1.19 ˂.001* 
Poverty Income Ratio -0.199 0.051 0.81 ˂.001* 
Smoking Status -0.189 0.154 0.82 0.22 
Depression  0.789 0.219 2.20 ˂.001* 
Social Network 0.005 0.009 1.00 0.554 
Financial Support 0.112 0.179 1.11 0.531 
Emotional Support -0.074 0.324 0.92 0.82 
Depression*Social Network -0.036 0.033 0.96 0.272 
Depression*Financial Support 0.31 0.478 1.36 0.568 
Depression*Emotional Support -1.874 0.009 0.15 .004* 
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Discussion 
We sought to extend work conducted by Johnson and colleagues by examining 
the relationship between depression, social support and risk profile memberships. The 
latent profile analysis revealed a low risk profile and an inflammatory risk profile. 
Consistent with Johnson and colleagues, members of the low risk profile exhibited 
increased levels of albumin and lower levels of all other biomarkers.  A relationship has 
been found between increased levels of albumin and reduced cardiovascular risk and 
mortality.  For example, a cohort study examining albumin levels in elderly adults found 
that all-cause mortality rates decreased with increasing albumin levels (Horwich et al., 
2008). Therefore, replication of a “low risk profile” may validate the presence of an 
overall physiological low risk profile.   Also consistent with previous findings, was the 
manifestation of an inflammatory risk profile.  Inflammatory risk, particularly with 
elevated levels of glycohemoglobin and homocysteine, has been shown to advance 
atherosclerosis and increase the risk of a vascular event (Hackam & Anand, 2003; Sander 
et al., 2006).  Patterns of C-reactive protein and albumin in the inflammatory risk profile 
were similar to systematic inflammatory responses in chronic diseases such as cancers 
and cardiovascular diseases while increasing the likelihood of all-cause mortality.(Kuller 
et al., 1991; Menon et al., 2005) 
We found that depression was significantly associated with membership in the 
inflammation risk profile. Prior research examining the relationship depression and 
inflammation has been mixed (Vogelzangs et al., 2012; Whooley et al., 2007)  Yet 
growing evidence suggests that depression may augment production of C-reactive protein 
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as suggested by our findings. The effects of depression on inflammation can been seen as 
early as childhood. Miller & Cole (2012) found that depressed individuals with a history 
of childhood adversity showed increased in C-reactive protein.  Further, the authors 
found that participants who experienced depression and childhood adversity experienced 
a heightened immune response over a 6 month period. (Miller & Cole, 2012). This 
suggests that the association between effects of depression on the immune response may 
be persistent across the lifespan.  (Alesci et al., 2005; Bouhuys, Flentge, Oldehinkel, & 
van den Berg, 2004; Kahl et al., 2005).   
Two main theories of social support, independent effects and buffering effects, 
portray how social support could reduce the inflammatory risk associated with depression 
(S. Cohen & Wills, 1985; House et al., 1988). Prior research has found that the size of the 
social network, emotional and financial support predicted increased immune reactivity 
(Loucks et al., 2006; Mezuk, Roux, & Seeman, 2010).  However, we did not find any 
evidence of that social support yielded independent effects on inflammatory risk. 
Alternatively, the buffering hypothesis suggests that social support is advantageous to 
health when stressors, such as depression, threaten health. Thus social support has been 
shown to buffer the harmful effects associated with these stress (Bell, Thorpe, & LaVeist, 
2010; Loucks et al., 2006; Mezuk, Roux, et al., 2010).  We did find that emotional 
support moderated the relationship between depression and inflammatory risk 
membership such that an increase in emotional support significantly decreased the 
association between depression and inflammatory risk. This was consistent with evidence 
that high social support buffers the relationship between stress and inflammatory risk 
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(Mezuk, Roux, & Seeman, 2010).   Therefore, the results of our study strengthens the 
assertion that social support may buffer against the deleterious health effects of 
depression.   Our findings suggests that the mechanism in which this occurs may be 
attributed to a reduced inflammatory response.  
In regards to the weathering hypothesis, these findings are consistent with 
evidence that suggests age alone does not fully contribute to inflammatory risk (Johnson, 
nd).  Being African American, older in age, and low socioeconomic status was associated 
with inflammatory risk. The impact of depression with access to little financial resources 
may increase inflammatory risk among African Americans, though we did not find the 
financial support would impact the relationship between depression and inflammatory 
risk. Depression may serve as a chronic stressor and accelerate biological weathering 
over the lifespan beginning in an early adulthood (Geronimus, 2000; Geronimus & 
Thompson, 2004). This is possibly bolstered by evidence that African Americans are 
more susceptible to economic and social stressors that increase the likelihood of 
depressive symptomology (Mezuk, Rafferty, et al., 2010).  In addition, the weathering 
hypothesis suggests that minorities more frequently report racism and discrimination 
which has been found to increase perceived stress and depressive symptomology (Banks 
& Kohn-Wood, 2007; Brody et al., 2006; Clark et al., 1999; Flores et al., 2008; Sellers et 
al., 2006).     Thus, future research should examine depressive symptoms as a potential 
mediator between experiences of racism and discrimination and physiological outcomes.  
The present study held several limitations. NHANES is a rich national dataset that 
allows for examination of racial differences in biological risk across the lifespan. 
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However, in order to examine the relationship between depression, social support, and 
risk profile membership, we were limited to a sample age 40 and older. This limited our 
ability to fully assess the relationship of the variables across the lifespan.  Further, this 
data set did not include measures of primary mediators (e.g., cortisol, norepinephrine, 
epinephrine). Though examining secondary mediators of stress is informative, 
investigation of primary mediators of stress is important for linking biological risk due to 
stress to clinical outcomes.  Further we only studied emotional support, financial support, 
the size of the social network. It is possible there are other mechanism of support such as 
informational support may influence the relationship between depression and 
inflammatory risk.   
Our findings suggest that different stressors may drive specific physiological 
responses more so than others, enhancing how researcher conceptualize cumulative 
physiological burden or allostatic load. This provides several opportunities to enhance 
treatment options and tailored preventative interventions to reduce cardiovascular risk 
among those who experience depression.    For example, clinical interventions may 
consist of screening for inflammatory biomarkers for African Americans who report 
depressive symptomology. Johnson and colleagues found that inflammatory risk group 
that consisted of a primarily African American women with an average age of 33. 
Therefore, screening of inflammatory markers should be recommended for African 
Americans, particularly those who report depressive symptomology.   Moreover, 
enhancing cultural specific coping efforts with other resources such as emotional support 
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may be important in reducing biological risk for African Americans, particularly those 
who experience depression.
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  CHAPTER VI 
  
 CONCLUSION 
 
This dissertation sought to achieve two aims: (1) Apply Latent Profile Analyses 
(LPA) to continuous level biomarkers in the National Health and Nutritional Examination 
Survey (NHANES) data to segment the participants into a set of qualitatively distinct 
biological risk profile subgroups and (2) expand upon the model in Aim 1 to examine the 
association between depression, social support and risk profile membership. To address 
Aim 1, I tested the hypothesis that latent profile analysis would identify at least five 
profiles associated with cardiovascular risk (Hypothesis 1a.). However, latent profile 
analysis only identified four cardiovascular risk profiles (i.e. vascular risk, kidney risk, 
inflammatory risk, and low risk). It is possible this could have occurred as a result of the 
use of different biomarkers used in the latent profile analysis. Preliminary work using 
cluster analysis to develop cardiovascular risk profile groups used LDL and HDL to 
develop the profiles. Upon further research, total cholesterol was identified as a more 
favorable measure as it incorporated both HDL and LDL.  However, this may have 
influenced the presence of a cholesterol risk profile.  
It was also hypothesized that an increase in age will predict membership in higher 
risk profiles (Hypothesis 1b).   We found evidence that this hypothesis was correct.   
Increase in age was associated with vascular, kidney, and inflammatory risk. We also 
 
84 
 
found that inflammatory risk was observed in group where the mean age is 33. This 
group were more likely to be African American and female.  These findings well align 
with the weathering hypothesis which suggests African American women may 
experience symptoms of biological weathering beginning in their 20s. These findings also 
support the hypothesis that risk profile membership will differ by sex.  The working 
hypothesis for this dissertation asserted that the males will more likely have membership 
in the kidney risk while females will more likely hold membership in vascular risk 
profiles (Hypothesis 1c). Our results indicate that males were at least 20 times more 
likely to be in the kidney in profile and the vascular risk profile. However, females were 
much more likely to be in the inflammatory risk profile. This may give credence to the 
notion that the driving biological mechanisms of allostatic load may differ by sex.  
 A sample of participants 40 and over were required to address Aim 2 based on the 
availability of the variables of interest.   In this sample, latent profile analysis identified 
two risk profiles; low risk and inflammatory risk. It was hypothesized that an increase in 
depression scores would result in membership in risk profiles (Hypothesis 2a). We found 
evidence that this hypothesis was true as an increase in depression scores significantly 
increased odds of membership in the inflammatory risk profile. These results are 
consistent with literature that suggests that depression increases cardiovascular risk. 
Further, these findings may provide evidence that the mechanism in which this occurs is 
through an inflammatory response.  
 We also examined the hypothesis that social support would increase the 
probability of membership in a low risk profile. We examined three aspects of social 
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support; financial, emotional, and social network. We did not find evidence that social 
support was significantly related to inflammatory risk. However, we find evidence that 
social support moderates the relationship between depression and inflammatory risk 
(Hypothesis 2c).  Emotional support was shown to significantly reduce the positive 
association between depression and inflammatory risk. However, financial support and 
social network showed no moderating effect.  
Future Study 
This dissertation project finds evidence that there are varying biological drivers of 
allostatic load. This adds to the literature that suggests that physiological responses to 
different stressors are not identical. Therefore, a specific stressor may elicit a specific 
physiological response that may differ from other stressors. For example, those who may 
suffer from chronic depression may have inflammatory risk compared to those who may 
experience a lifetime of financial hardship. Future studies should investigate whether this 
premise holds true across different stressors in the development of cardiovascular risk 
profiles. In addition, the weathering hypothesis suggests that minorities frequently report 
racism and discrimination. Future study should examine the impact of reported 
experiences of racism and discrimination among minorities as these experiences may 
have specific “drivers” of allostatic load, particularly in the context of cardiovascular 
disease disparities.     Lastly, depression and cardiovascular disease risk has been shown 
to have a bidirectional relationship. Future research should examine the effect on 
cardiovascular risk profile on the subsequent diagnosis of depression or having 
depressive symptoms. 
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